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Abstract
Inappropriate expression of nicotinic acetylcholine receptors in the central nervous 
system is associated with nicotine addiction, Alzheimer’s disease, Parkinson’s disease 
and other disorders. Modulators (drugs) have the potential to restore circuit properties 
that arise from inappropriate expression of nicotinic receptor’s. Compounds that 
interact with allosteric sites have a distinct advantage over agonists and partial agonists, 
in that, they retain normal activation patterns by allowing binding of the endogenous 
ligand. Positive allosteric modulators boost the receptors ability to respond to agonist. 
Studies of these modulators constitute a first step toward the identification and 
development of better compounds that minimize signaling errors at cholinergic 
synapses. We have used single molecule methods to investigate the action of a novel 
positive allosteric modulator, desformylflustrabromine (dFBr), on nicotinic receptors.
Our studies were focused on the a4p2 subtype of nicotinic receptors in the brain.
These receptors exist in two forms with low sensitivity (a43022) or, alternatively, high 
sensitivity (a42023) to agonist. Our experiments allowed us to develop detailed gating 
models for high and low sensitivity receptors, as well as gain new insights regarding the 
mechanisms that underlie potentiation by allosteric modulators. We found that dFBr 
potentiates low sensitivity receptors by destabilizing desensitized states of the receptor. 
In contrast, potentiation of high sensitivity receptors arises from a synchronization of 
openings following an application of agonist due to an increase in the opening rate. 
Based on our results we now have a better understanding of the advantages of dFBr on 
high and low sensitivity receptors.
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Chapter 1: Overview and Research Aims
1.1 Background
1.1.1 General Overview of Synaptic Transmission
At chemical synapses, invasion of the axon terminal by the action potential 
results in opening of voltage gated calcium channels and calcium influx. Elevated levels 
of calcium ions trigger fusion of synaptic vesicles that contain neurotransmitter with the 
presynaptic membrane. Neurotransmitter is released into the synaptic cleft and diffuses 
a short distance (~30 nm) where it binds to postsynaptic receptors. Binding of 
neurotransmitter biases the receptor to open, allowing cations to enter the post synaptic 
cell. If a threshold is reached in the membrane potential, then an action potential is 
produced. Activation of excitatory receptors leads to cation influx resulting in 
depolarization of the postsynaptic membrane (Albuquerque et al., 2009).
Neurotransmitter receptors affect signals that are sent from one neuron to 
another and therefore harbor an opportunity for intervention by drugs. Inappropriate 
expression of nicotinic receptors in cholinergic systems is associated with diseases and 
disorders such as nicotine addiction and Alzheimer’s disease. Nicotine addiction is a 
complex disorder, but upregulation and consequent overexpression of nicotinic 
receptors in the brain is a primary contributing factor in the reinforcing nature of nicotine 
addiction (Fenster et al., 1999; Buisson and Bertrand, 2001). While nicotine addiction is 
thought to occur by an overexpression of receptors, the loss of cholinergic receptors is 
likely to contribute to cognitive decline in Alzheimer’s disease and other
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neurodegenerative disorders. Alzheimer’s disease emerges when there is 
underexpression of nicotinic receptors in the brain, with cell loss and loss of receptors 
being correlated to a loss of cognitive abilities in patients with the disease (Nordberg 
and Winblad, 1986). If there are too few receptors on postsynaptic cells, then signals 
are too weak, and neurons are unable to effectively communicate. If too many 
receptors are present and are overexpressed, then the resulting signals can become 
too strong. In scenarios where circuits are not working properly due to over- or 
underexpression of nicotinic receptors, then a strategy is needed to alter receptor 
responsiveness.
Two competing strategies for correcting errors in cholinergic signaling include the 
use of partial agonists or positive allosteric modulators. While partial agonists (Coe et 
al., 2005) are one strategy for modulation of nicotinic receptors, they an improper choice 
due to competition with acetylcholine for binding. Continuous exposure of receptors to 
agonist and partial agonists can produce receptor desensitization, resulting in receptors 
being unavailable for further activation. Alternatively, a compound that interacts with 
allosteric sites can be utilized for correcting cholinergic signals, allowing retention of the 
normal activation pattern of the endogenous agonist. Positive allosteric modulators are 
compounds that are unable to or produce little receptor activation on their own, and 
instead boost the receptors ability to respond to agonist. These compounds have a 
potential advantage in not only preventing drug induced desensitization, but also by 
restoring normal levels of acetylcholine activity, yielding better functional outcomes 
compared to partial agonists.
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Given that inappropriate expression a4p2 receptors are associated with a variety 
of CNS disorders an effective therapeutic intervention would require a library of 
allosteric modulators with unique functional properties. Selective positive allosteric 
modulators are important in the development of compounds with specific functional 
properties. Studying the mechanism of action for positive allosteric modulators helps 
cultivate an understanding of the effects a drug has on a cholinergic synapse. 
Establishing a model constitutes a first step toward the development and identification 
of better compounds that can correct errors in cholinergic signaling. In this thesis we 
investigated the action of a particular modulator called dFBr. A long term goal of these 
studies is to facilitate the directed development of new and better compounds.
1.1.2 Characteristics of a4fi2 Receptors
In mammals, neuronal nAChRs are transmembrane proteins with a pentameric 
arrangement of subunits arranged around a central pore. Neuronal nAChRs are formed 
from a collection of nine a (a2-a7,a9,a10), and three p (P2-P4) subunits (Changeux, 
2010). The major nAChRs within the brain are homomeric receptor composed of a7 
subunits and heteromeric receptors composed of a4 and p2 subunits (Khiroug et al., 
2004; Moore and McCarthy, 1995). The heteromeric receptors can assemble in 
alternate forms alternate forms, low sensitivity (LS) receptors consisting of three alpha 
and two beta subunits (a43p22) that bind ACh and nicotine with low affinity (EC50 ~100 
^M), and high sensitivity (HS) receptors consisting of two alpha and three beta subunits 
(a42p23) that bind ACh and nicotine with high-affinity (EC50 ~1 ^M) (Nelson et al., 2003;
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Khiroug et al., 2004; Buisson et al., 1996). High sensitivity receptors require a relatively 
low concentration of agonist in order to produce a half maximal response, (low EC50). 
Low sensitivity receptors require higher concentrations in order to elicit a half maximal 
response. Isolated a4p2 receptors display two distinct conductance’s, ~20 pS for the 
HS subtype and ~30 pS for the LS subtype (Charnet et al., 1992; Buisson et al., 1996;
Li and Steinbach, 2010).
Most work on the physiological properties of a4p2 nAChRs has been done in 
oocytes and HEK 293 cells. When equivalent amounts of a4 and p2 cDNAs are 
injected into oocytes, both HS and LS receptors are expressed in equivalent amounts, 
whereas in HEK293 cells the receptors predominantly assemble as the LS subtype, 
comprising 80% of the receptor population (Harps0 e et al., 2011). Using HEK293 cells 
is an advantage, in that, it allows us to compare our single-channel data to whole-cell 
data that has been previously obtained from studies utilizing this cell line. This allows 
us to determine whether our models are supported by whole-cell data.
nAChRs binds agonists such as the endogenous agonist ACh or exogenous 
agonist nicotine (Changeux, 2010). In the absence of agonist, nAChRs are in a closed, 
nonconductive state. Binding of ACh leads to channel opening and cation influx, 
however, in the continued presence of agonist receptors become unresponsive. This 
phenomenon is called desensitization. If agonist is removed when receptors are mostly 
open, then receptors have the chance to close (deactivate) allowing them to be 
available to immediately reopen upon exposure to agonist. In contrast, when receptors 
are exposed to extended periods of elevated levels of agonist then receptors are not
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immediately available for reactivation due to being desensitized. Once desensitized 
receptors require time to return to a resting state.
Nicotinic receptors play interesting and unusual roles within functional circuits, 
with some being activated quickly, while others are slower. In classical transmission the 
concentration profile is fast, in this situation it is unlikely that nAChRs will desensitize. If 
the concentration profile is fast then receptors will open for a short time, ACh will unbind 
and the receptors will close. In volume transmission model, agonist could remain 
elevated for extended periods. In this scenario diffusion of acetylcholine through 
extracellular fluid would activate extrasynaptic nAChRs (Agnati et al., 1995). Delaying 
transmitter removal gives receptors the opportunity to enter desensitized states.
While the precise functional roles of nAChRs in cholinergic transmission are 
unclear, reduction in the total number of available nicotinic receptors has been linked to 
a wide variety of neurodegenerative disorders and diseases including: schizophrenia, 
Parkinson’s disease, autism, Alzheimer’s disease, and PTSD (Breese et al., 2000; Terry 
et al., 2015; Dome et al., 2010; Hajos and Rogers, 2010; Dani and Bertrand, 2007). 
Alzheimer’s is a catastrophic disease accompanied by a loss of cholinergic cells within 
the brain, and reduced expression levels of a4 and a7 containing nAChRs (Martin-Ruiz 
et al., 1999; Guan et al., 2000; Whitehouse and Au, 1986; Marutle et al., 1999).
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1.1.3 Diseases Associated with Cholinergic Transmission
1.1.3.1 Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder with patients 
eventually showing a loss in cognition and control of daily activity over time. p-amyloid 
(Ap) is an important factor in the initiation and promotion of AD, and soluble AP42 
oligomers are currently thought to be the primary cause of the disorder. Investigations 
into the role of Ap in AD patients show significant reductions in the number of nAChRs 
(37 to 57%) (Marutle et al., 1999). The degree of high affinity nicotinic agonist binding 
in the temporal cortex is correlated to the severity of AD, with a deficiency of high affinity 
nAChR binding sites linked to a loss of cognitive abilities (Wevers et al., 1999; Martin- 
Ruiz et al., 1999; Guan et al., 2000; Whitehouse and Au, 1986; Nordberg and Winblad, 
1986).
A possible treatment option for alleviating the symptoms in AD patients is to 
elevate the concentration of ACh within the brain by using compounds that inhibit 
acetylcholinesterase (ChE) (Christner et al., 2003; Paterson and Nordberg, 2000). 
Galantamine is a ChE inhibitor that also interacts directly with nAChRs. While ChEs like 
galantamine improve cognitive function, the numerous peripheral and central nervous 
system side effects commonly associated with ChE compounds outweighs their benefits 
(Christner et al., 2003). These side effects coupled with ChEs being unable to prevent 
or reverse the progression of AD, means other options may be more suitable to address 
nAChR dysfunction in the disease. Additional treatment options include the 
development of selective nAChR agonists, partial agonists or positive allosteric
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modulators (PAMs). The agonist nicotine has been shown to be beneficial for many 
neurodegenerative disorders including AD, but the addictive properties of nicotine make 
this compound unsuitable as a treatment option (Levin and Rezvani, 2000; Rusted and 
Warburton, 1992; Jones et al., 1992). The partial agonist varenicline has recently been 
shown to disrupt the action between fibrillary Ap and a7 nAChRs, due to a possible 
overlap in binding sites (Ni et al., 2013). While there is interest in agonists and partial 
agonists as a potential treatment option for individuals with AD, these choices offer little 
in the area of selectivity (Pandya and Yakel, 2011). Compounds such as PAMs are 
better suited for boosting nAChR function in disorders such as AD due to their ability to 
interact with a site distinct from ACh, thus potentially yielding better functional 
outcomes. Desformylflustrabromine is a PAM for the a4p2 receptors (Sala et al., 2005) 
has promise as a future therapeutic option in the treatment of AD. Along with the 
compounds observed potentiation on a4p2 receptors, it has an additional unique 
property of being able to interfere with the inhibitory action of Ap1-42 witha4p2 receptors 
(Pandya and Yakel, 2011).
1.1.3.2 Nicotine Addiction
Tobacco use and nicotine addiction are serious risk factors in the development of 
cancer, heart and respiratory diseases. Over 6 million deaths each year are a result of 
tobacco use, 5 million of those deaths are the result of direct tobacco use and over
600,000 deaths due to secondhand smoke (World Health Organization, 2015). The 
primary compound responsible for strong addiction to smoking is nicotine.
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Nicotine is an effective nicotinic receptor agonist that displays relatively high 
affinity for nAChRs, exhibiting an EC50 between 2-14 ^M (Buisson et al., 1996; Buisson 
and Bertrand, 2001; Paradiso and Steinbach, 2003). Nicotine addiction is thought to be 
the result of profound desensitization, triggering upregulation of a4p2 receptors. In 
a4p2 nAChRs ACh and nicotine are similar with regards to how fast desensitization 
develops, but receptors stay desensitized for longer in the presence of nicotine 
(Paradiso and Steinbach, 2003). nAChRs are able to increase their expression 
(upregulation) when chronically exposed to nicotine, the receptor exhibiting the greatest 
upregulation being a4p2. The underlying mechanism for upregulation is not agreed 
upon, however, it is universally thought that upregulation of high affinity receptors is a 
main contributing factor in the reinforcing nature in nicotine addiction (Staley, 2006; 
Buisson and Bertrand, 2001; Fenster et al., 1999).
Nicotine can influence the mesocorticolimbic dopamine system (MDS), a 
dopaminergic pathway that leads from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAcc) and limbic systems, the primary reward system of the brain. Figure
1.1 is a visual guide to interactions of some neurons in the VTA and where various 
subtypes of nAChRs are presumed to be located. Nicotine’s influence leads to 
increased levels of extracellular dopamine in the ventral striatum and pre-frontal cortex. 
Although the MDS is composed of many sections, nAChR’s expressed on dopaminergic 
cells and inputs into these cells contribute to the rewarding effects of nicotine (Dome et 
al., 2010; Mansvelder et al., 2002, 2007). Nicotine administration into the VTA results in 
an increase in dopamine release into the NAcc. This increase is due to the activation of 
a4p2 receptors on dopaminergic and GABAergic cells, and a7 nAChRs on
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glutamatergic nerve terminals. Exposing a4p2 receptors on the GABAergic and 
dopaminergic terminals to nicotine causes receptors to undergo rapid desensitization 
(Dome et al., 2010; Mansvelder and McGehee, 2000). While a4p2 receptors are 
heavily affected by nicotine, the concentration is not high enough to desensitize a7 
nAChRs on glutamatergic inputs into the VTA. Thus, nicotine can activate the 
glutamatergic nerve endings, further triggering the dopaminergic cells of the VTA. 
Dopaminergic neurons are under tonic inhibitory control by GABAa  and removal of this 
inhibition leads to increased activity of dopaminergic neurons, which in turn leads to an 
increase in dopamine release in the NAcc (Dome et al., 2010; Mansvelder et al., 2007; 
Mansvelder and McGehee, 2000; Mansvelder et al., 2002).
The primary contributor for the pleasurable effects of nicotine is the 
desensitization of a4p2 receptors, leading to disinhibition of dopaminergic neurons 
within the VTA. Once nicotine dependence has developed it requires nicotine 
reinforcement and is difficult to quit. The only smoking cessation treatments currently 
available are varenicline and nicotine replacement therapies. Other compounds have 
the potential to be useful, such as cytisine, bupropion, NS9283 and dFBr (Mohamed et 
al., 2015). While varenicline and cytisine have been found to be as effective as nicotine 
replacement therapies for nicotine addiction, very little research has been done on the 
effectiveness of PAMs. Whether these compounds will disrupt nicotine specific 
desensitization and aid in smoking cessation remains to be seen, with more research in 
this area being required.
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1.1.4 Positive Allosteric Modulators of a4p2 Receptors
The benefit of PAMs is that they occupy binding sites distinct from that of 
acetylcholine, thereby altering the receptors responsiveness to the endogenous ligand. 
PAMs have the ability to increase the probability of channel opening, while potentially 
decreasing the agonists potential for receptor desensitization (Williams et al., 2011; 
Pandya and Yakel, 2011; Hajos and Rogers, 2010). PAMs demonstrate a wide variety 
of modulatory actions on a4p2 receptors and can potentiate maximal amplitude 
responses differently. NS206 and dFBr are PAMs that affect both forms of a4p2 
nAChRs. However, both potentiate max amplitude responses in a different manner. 
NS206 is thought to increase efficacy by an increase of the mean open time of the 
receptor for both stoichiometries, whereas our single channel analysis of dFBr found 
that it potentiation occurs by destabilizing desensitized states for the LS subtype, and 
increasing mean open time for the HS subtype (Olsen et al., 2013). PAMs cannot 
produce receptor activation on their own and can affect ligand gated ion channel 
function in a couple of ways, by either influencing channel conductance or by altering 
channel gating. (Williams et al., 2011; Pandya and Yakel, 2011; Hajos and Rogers, 
2010).
A PAM can increase the apparent affinity (potency) on the receptor for agonist, 
while simultaneously not increasing the maximal response amplitude (efficacy). A 
modulator can be a PAM, having an effect on one of those properties while 
simultaneously not affecting the other. Several PAM’s of a4p2 nAChRs currently exist
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and affect the channel in a variety of ways. Some are selective for one subtype of 
a4p2, while others affect both subtypes differently.
1.1.4.1 NS9283
Preclinical studies have shown that NS9283 shows promise in the treatment of 
cognitive disorders (Timmermann et al., 2012; Lee et al., 2011). NS9283 is a PAM that 
selectively increases ACh potency for the LS subtype of nAChRs. It is thought to exert 
potentiation predominantly through reduction in the rate of deactivation of the receptor 
with the mechanism of action bearing resemblance to that of benzodiazepines at the 
GABAA receptor. With ultra-short applications of high concentrations of (1 mM) ACh, 
current decay is substantially slower with NS9283 (Grupe et al., 2013). The PAM does 
not have an effect on desensitization produced by ACh and was incapable of 
reactivating desensitized receptors (Grupe et al., 2013). The mechanism of NS9283 is 
thought to not involve a decrease in macroscopic desensitization, but rather via slowing 
the rate at which the receptor deactivates. However, we have shown for simulations 
involving dFBr that the deactivation time course of LS receptors is not a simple 
reflection of channel closing, but also involves entry into desensitized states. Therefore, 
the mechanism of modulation for NS9283 could involve the destabilization of a 
desensitized state, resulting in what appears to be a slowing of deactivation. The 
presence of NS9283 in the synaptic cleft would prolong the agonist-bound receptor 
state and ultimately result in an increase in charge transfer. Other PAMs, like dFBr, 
exhibit potentiation via an increase in mean open time, as well as decreasing ACh- 
induced macroscopic desensitization (Sala et al., 2005; Weltzin and Schulte, 2010).
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1.1.4.2 Desformylflustrabromine (dFBr)
Desformylflustrabromine is an indolic alkaloid isolated from the marine bryozoan 
Flustra foliacea and was identified as a selective PAM of a4p2 nAChRs (Sala et al., 
2005). dFBr has the ability to potentiate ACh-induced responses at concentration less 
than 10 ^M and inhibit responses at concentrations greater than 10 ^M. In the 
presence of dFBr, dose response curves show a decrease in the EC50 and an increase 
in the maximal response curve. dFBr exhibits an EC50 of 120 nM and IC50 of 150 ^M, 
and the observed inhibition invoked by dFBr is thought to be due to the displacement of 
ACh binding (Kim et al., 2007). Rebound currents on washout of ACh/dFBr were seen, 
indicating the presence of open channel block. Rebound currents occur when the open 
channel blocker is released while agonist is still bound to the receptor (Kim et al., 2007).
Studies on the therapeutic potential of dFBr are still in their early stages, but a rat 
self-administration study showed that dFBr has qualities that would make it an ideal 
candidate for smoking cessation treatments. Pretreatment of dFBr, as well as treatment 
while rats were engaged in self administration, reduced long term nicotine self­
administration behavior. It was also found that dFBr was present in cerebral spinal fluid 
at one third the concentration of that within the blood stream of administered rats. This 
provides evidence that dFBr crosses the blood brain barrier, but at one-third the 
concentration found in the bloodstream (Liu, 2013). Effective transit across the blood 
brain barrier is important if a compound is to be considered for smoking cessation 
therapies.
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The in vitro effects of dFBr have been previously studied, but the mode by which 
dFBr selectively potentiates a4p2 nAChRs remains to be determined. The existing 
single-channel information on the effects of dFBr are limited and the information that is 
available briefly demonstrates that dFBr increases the channel-opening probability. It is 
speculated that the effects of dFBr occur because of an increase in the rate constants 
designated for channel opening and closing (Sala et al., 2005). A complete 
understanding of the mechanism of modulation is unavailable for the individual receptor 
subtypes. Gaining an understanding of the mechanism would improve our 
understanding of the potential effects dFBr has on a cholinergic synapse as well as aid 
in the development of future allosteric modulators. The selectivity that dFBr 
demonstrates makes it a valuable asset for further investigation involving modulation of 
a4p2 receptors.
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1.1.5 Modeling
1.1.5.1 Classical Mechanisms
The earliest functional models for nAChR kinetics were made by del Castillo and 
Katz in 1957 and described the similarity between enzyme-substrate and receptor 
ligand interactions (Figure 1.2A) (Castillo and Katz, 1957). This model was further 
elaborated on by Katz and Theslaff in 1957 to account for desensitization and led to a 
cyclical like scheme (Figure 1.2B) (Katz and Thesleff, 1957). This cyclical scheme was 
expanded to include two open states, and is one of the more common mechanisms 
utilized for analyzing kinetic data (Edelstein et al., 1996).
In 1965, Monod-Wyman-Changeux (MWC) put forth an allosteric transitions 
theory in order to explain cooperative ligand binding observed in oligomeric proteins. 
This approach has had a large effect on the understanding of the cooperative 
interactions between hemoglobin and allosteric enzymes and has further been extended 
to neuronal transmembrane receptors. Allosteric theory has several components to it:
(i) allosteric proteins are oligomers where the individual subunits are equivalent; (ii) 
each subunit contains a site for a ligand to bind to it; (iii) subunit conformations are 
restricted based on the interactions with the subunits around them; (iv) allosteric 
oligomers have access to two conformational states, O and C; (v) binding of ligand to 
one site alters the affinity of additional sites for ligand; (vi) molecular symmetry is 
conserved when an oligomer goes from one conformational state to another (Monod et 
al., 1965). Typical MWC model is shown in Figure 1.2C. Typical nAChR mechanisms, 
as shown in Figure 1.3A, give adequate fits with the fit often being improved by adding
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an additional shut state following the open state, like a desensitized state. Our nicotinic 
HS and LS receptor mechanisms use the MWC model as a base.
1.1.5.2 Models Established for the HS and LS a4p2 Receptors
Determining the mechanisms of modulation for a4p2 nAChRs in the presence of 
dFBr is important for enhancing our understanding of the potential impact allosteric 
modulators could have on a cholinergic synapse. In this thesis we utilized single 
molecule methods to investigate the mechanism by which dFBr potentiates nAChRs. 
We provide the first understanding of the mechanism for the two a4p2 nicotinic receptor 
subtypes. We have developed full gating models that provide a fairly accurate 
representation of function for both forms of the receptor, LS (Figure 1.3B) and HS 
(Figure 1.3C). These models were used to perform simulations and determine the 
effects dFBr would have under a variety of agonist concentration profiles. The 
mechanisms of modulation are determinant on how the receptor subtypes are 
expressed within a system, with receptors changing their agonist concentration profile 
when they are modulated.
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1.2 Research Aims
The focus of my research is establishing gating models for the HS and LS a4p2 
receptors and determining the mechanisms of modulation of the positive allosteric 
modulator dFBr. These goals were accomplished in two aims.
1.2.1 Aim 1: Establishment of Gating Models for the HS and LS a4p2 Receptors
Before a modulators mechanism can be determined on a single channel level a 
baseline needs to be established. This is accomplished by determining gating models 
in agonist alone for each of the receptor subtypes. In Chapter 2, a 7 state gating model 
is established for the low sensitivity a4p2 nAChRs under low concentrations of agonist 
(<1 ^M ACh). The 7 state model contained two ligand binding reactions C1 ^ C 2  and 
C2^C3, two open states; a monoliganded state off of C2 (O1) and a diliganded state 
off of C3 (O2), as well as two desensitized states, one off of C3 (D1) and O2 (D2). In 
Chapter 3, the high sensitivity a4p2 nAChRs required an 8 state model using data with 
concentrations ranging from 0.1 ^M to 10 ^M ACh for construction. The 8 state model 
contained two ligand binding reactions C1^C2 and C2^C3, mono and diliganded 
interconnected open states (O1 off C2 and O2 off of C3), and three desensitized states 
with two off of O2 (D1 and D2) and one off of C3 (D3).
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1.2.2 Aim 2: Modulation of a4p2 nAChRs by dFBr in Low Concentrations of Agonist
Once baseline models have been established in the absence of modulator then 
the mechanism of modulation by dFBr for the LS and HS receptors can be elucidated. 
Analysis of the mechanisms for the LS and HS receptors revealed two distinct 
mechanisms of modulation for dFBr on these receptors. In the latter half of Chapter 2 
the mechanism of modulation of dFBr on LS a4p2 receptors are discussed in detail, 
with dFBr exhibiting potentiation by destabilizing desensitized states. Chapter 2 also 
contains a discussion on slow solution exchange in oocytes and its contribution in peak 
responses. Some of the discrepancy between our data and oocyte data is due to the 
slow response profile in oocytes. In Chapter 3 the mechanism of modulation of dFBr on 
HS receptors is determined, where it is found that dFBr’s effects are dependent upon 
the concentration of agonist. At low concentrations of agonist dFBr increases the 
mono-liganded open state lifetime, while at high concentrations an increase in the 
probability of entering the diliganded open state from the diliganded closed state is 
seen. Chapter 3 also contains a short discussion on the presence of HEPES and the 
effects the buffer may have on the HS data.
1.3 Hypothesis
1.3.1 dFBr Can Modulate a4p2 Receptors in Low Concentrations of Agonist
This hypothesis is based on the previous studies done by Weltzin et al and
utilizes single-channel techniques (Weltzin and Schulte, 2010). This hypothesis
addresses whether dFBr potentiates at low concentrations of agonist for the high and
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low sensitivity a4p2 nAChRs. We express human a4p2 receptors in a mammalian cell 
line and use patch-clamp methods to record acetylcholine-evoked responses of HS or 
LS receptors in isolated patches of membrane. Unlike other methods, the single­
channel methodology allows us to limit receptor heterogeneity as well as subject 
channels to a low concentrations of agonist. Utilizing this technique, we can gather long 
steady state recordings and develop a basic gating model for both stoichiometric forms 
of the receptor, which will be further used to determine dFBr’s mechanism of 
modulation.
1.3.2 dFBr Modulates by Destabilizing Desensitized States for a4p2 Receptors.
This hypothesis is an extension of the previous hypothesis and relies on the 
establishment of a basic gating model. The models generated will help determine the 
mechanism by which dFBr potentiates the high and low-sensitivity stoichiometric forms 
of the receptors. It is thought that the primary mode of potentiation exhibited by dFBr is 
through an increase in the open probability of the receptor. This can be achieved a few 
different ways, including: an increase in the rate of entry into the open state, leading to 
an increased probability of opening, or decreasing the rates out of the open states 
leading to an increase in mean open lifetime. However, an increase in open probability 
is not the only mechanism by which a potentiator can modulate a receptor. Our 
hypothesis is that dFBr’s primary mode of action is by the destabilization of one or more 
desensitized states, leading to potentiation. The development of a model and 
elucidating the mechanism of modulation will help further the characterization and 
therapeutic benefits of dFBr, as well as future a4p2 PAMs.
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Figure 1.1: Interactions between VTA, NAcc and the Prefrontal Cortex. VTA: Ventral
Tegmental Area, NAcc: Nucleus accumbens, PFC” prefrontal cortex, Glu: glutamatergic
terminal, DA: Dopamingergic, GABA: GABAergic Nicotinic receptors found on these
terminals are labeled, with lines for the specific area the nicotinic receptor is located.
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Figure 1.2: Classical Mechanisms. (A) Mechanism proposed by del Castillo and Katz 
(1957) to describe receptor-ligand interactions. (B) More recent model developed by 
Katz and Thesleff (1957) and modified to include two ligand binding sites as well as 
desensitized states. (C) A Monod-Wyman-Changeux (MWC) mechanism. A is agonist, 
R is receptor in the closed conformation, D is a receptor in the desensitized state, and O 
is receptor in the open conformation.
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Figure 1.3: Complex Mechanisms. (A) A common example of a mechanism used to 
describe the nicotinic receptor with two ligand binding steps and mono and di-liganded 
openings. (B) Mechanism used to fit LS a4p2 nAChR data. (C) Mechanism used to fit 
the HS a4p2 nAChR data.
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Chapter 2: Destabilization of Desensitized States of Low Sensitivity Nicotinic
Acetylcholine Receptors1
Abstract
A description of mechanisms that underlie modulation of nAChRs by allosteric ligands is 
critical for understanding the effects of modulation on cholinergic signaling in the CNS. 
We used single-channel methods to investigate the mechanism of potentiation of the 
human low-sensitivity, a43022 nicotinic acetylcholine receptor by the allosteric ligand 
desformylflustrabromine (dFBr). Markov model analysis of steady-state, low 
concentration data from receptors expressed in HEK293 cells yielded a 7 state model 
with unique rate constants for naive and modulated receptors. The model consisted of 
two sequential binding reactions, mono- and diliganded open states, and two 
desensitized states, D1 and D2, accessible from the diliganded closed state and 
diliganded open state, respectively. We found that dFBr decreased the mean lifetimes 
of D1 (77 ms to 7.6 ms) and D2 (1.7 s to 490 ms). In simulations of macroscopic 
responses to concentration jumps, the EC50 of naive receptors was 74 ^M for peak 
currents, with a maximal Popen of 0.9, and profound desensitization (steady-state Popen < 
0.05 for all ACh concentrations) that developed rapidly (xfast = 70 ms) at high ACh 
concentration. dFBr increased the apparent affinity (EC50 = 18 ^M) of receptors and 
potentiated steady-state, desensitized responses (~ 5-fold). To investigate the 
contribution of destabilization of desensitized states to modulation, we examined state 
occupancy probabilities for both models when driven by various profiles of ACh
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concentration. Potentiation of desensitized responses arose from a lower probability of 
occupancy of D2, whereas destabilization of D1 slowed the initial, fast rate of 
macroscopic desensitization. Recovery from desensitization was substantially faster 
with dFBr and correlated with decreased lifetimes of D1 and D2. Finally, we found that 
desensitization of LS receptors plays an important role in hastening the time course of 
deactivation following a brief pulse of agonist concentration1
1 Demmerly, A., Edmonds, B.W. 2015. Destabilization of desensitized states underlies 
modulation of (a4)3(p2)2 receptors by desformylflustrabromine. J. Gen. Physiol.
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2.1 Introduction
A major class of nicotinic receptors in brain is formed from a4 and p2 
subunits that assemble as pentamers with alternate stoichiometries, a high- 
sensitivity (HS; a42023) receptor with an EC50 of ~ 1 ^M and a low-sensitivity (LS; 
a43p22) receptor with an EC50 of ~ 75 ^M (Nelson et al., 2003; Moroni et al., 
2006). a4p2 receptors are targets for compounds that bind allosteric sites and 
modulate responses to ACh. Compounds that potentiate and show selectivity for 
a4p2 receptors may mitigate signaling deficiencies in Alzheimer’s disease 
(Warpman and Nordberg, 1995; Martin-Ruiz et al., 1999) and other cognitive 
disorders associated with insufficient receptor activation or expression. As an 
alternative to allosteric ligands, partial agonists (Sullivan et al., 1997; Coe et al., 
2005) or inhibitors of acetylcholinesterase (Friedman, 2004) have been used as 
strategies to activate nAChRs; however, those options offer little opportunity for 
selectivity (Pandya and Yakel, 2011). Moreover, tonic occupation of orthosteric 
sites produces desensitization, resulting in a profound reduction in 
responsiveness to ACh (Paradiso and Steinbach, 2003). If cholinergic inputs are 
at least partially intact, allosteric ligands may yield better functional outcomes.
Novel, a4p2-selective allosteric ligands are of particular interest as leads 
for development of additional compounds with distinct functional properties. 
NS9283 is an allosteric modulator with selectivity for the LS a4p2 receptor 
subtype (Timmerman et al, 2012). In whole-cell recordings, NS9283 produces a 
marked increase in the potency of ACh with no apparent change in efficacy
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(Timmermann et al., 2012; Grupe et al., 2013). In response to brief, 1 ms 
applications of ACh, NS9283 prolongs the time course of deactivation (x 
increased from 18 ms to 65 ms); however, the time course of desensitization is 
unaffected, and desensitized receptors are not reactivated by application of the 
modulator (Grupe et al., 2013).
Desformylflustrabromine is a metabolite originally isolated from Flustra 
foliacea that potentiates a mixture (HS and LS) of a4p2 receptors, but not a3p4 
or homomeric a7 receptors (Sala et al., 2005). The reported mechanism of 
potentiation is different from NS9283. dFBr increases the potency and efficacy of 
ACh (Kim et al., 2007), yielding up to 3-fold potentiation of peak current at high 
agonist concentration. The observation that dFBr activates desensitized 
receptors in whole-cell recordings led to the hypothesis that potentiation arises 
from stabilization of open states relative to desensitized states (Weltzin and 
Schulte, 2010); however, this would require that for steps into high 
concentrations of agonist, a significant fraction of the receptors is desensitized at 
the time of peak current. In a study of nonstationary noise of a4p2 receptors 
expressed in HEK293 cells, the maximal open probability of LS receptors was 
reported to be large (> 0.8) (Li and Steinbach, 2010), which is at least 
inconsistent with marked potentiation of LS receptors for any mechanism other 
than recruitment of silent receptors (Fenster et al., 1999; Zhang and Steinbach, 
2003; Li and Steinbach, 2010).
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In this study, we used a single-channel approach to gain a better 
understanding of LS receptor gating and the mechanism of potentiation by dFBr. 
Gating models developed from low concentration data exhibited characteristics 
typical of whole-cell responses previously reported for LS receptors (Nelson et 
al., 2003; Li and Steinbach, 2010; Grupe et al., 2013). We found evidence for 
two desensitized states, both of which were destabilized by dFBr. Simulations of 
macroscopic responses showed that dFBr produced marked potentiation of the 
steady-state response and accelerated recovery from desensitization. At 
saturating agonist, the peak open probability of naive receptors was 0.9, and 
peak response was not potentiated.
2.2 Materials and Methods
2.2.1 Cell Techniques
HEK293 cells were maintained in Eagle’s Minimum Essential Medium 
(MEM; Sigma Aldrich) supplemented with 1% GlutaMAX (Gibco), 10 % bovine 
growth serum (Hyclone, Thermo Scientific), penicillin (200 U/mL; Cellgro), and 
streptomycin (200 pg ml-1; Cellgro), pH adjusted to 7.4. Cells were incubated at 
37°C in a humidified atmosphere of 5% CO2, passaged weekly and plated onto 
35mm tissue culture dishes (Becton Dickinson) two days prior to transfection. 
Human a4 and p2 cDNAs [provided in pcDNA3.1/Hygro vectors (Invitrogen) by 
Dr. Marvin Schulte, University of the Sciences in Philadelphia] were purified 
using a Plasmid Midi Kit (Qiagen) and transiently transfected (SuperFect
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Transfection Reagent, Qiagen) into HEK293 cells. Recordings were made 
approximately 2 days following transfection.
2.2.2 Electrophysiology Techniques
Desformylflustrabromine hydrochloride was obtained from Tocris. All 
other reagents, including acetylcholine chloride, were obtained from Sigma 
Aldrich. To minimize receptor rundown, patch-clamp recordings were made in 
the cell-attached configuration (Hamill et al., 1981). The membrane potential 
was nominally zeroed with a high K+ extracellular solution containing (in mM):
142 KCl, 5.4 NaCl, 2 CaCl2, 1.7 MgCl2, 5 HEPES, and 10 glucose, pH adjusted 
to 7.4. Pipette solutions were made by addition of either 1 ^M ACh or, 
alternatively 1 ^M ACh and 1 ^M dFBr to (in mM) 5.4 KCl, 142 NaCl, 2 CaCl2, 1.7 
MgCl2, and 5 HEPES, pH adjusted to 7.4, on the day of the experiment. All 
recordings were made at room temperature (~ 22°C).
Recording pipettes (thick-walled borosilicate glass; Warner Instruments) 
were pulled to a resistance of 10-14 MQ using a PMP-102 micropipette puller 
(MicroData Instrument, Inc.). To reduce pipette capacitance, tips were coated 
with Sylgard (Dow Corning). Prior to recording, the pipettes were front- and then 
back-filled with the pipette solution containing ACh with or without dFBr. Cells 
were viewed with a Nikon FN1 Eclipse compound microscope, and patches were 
made (minimum seal resistance 5 GQ) and then voltage-clamped at an applied 
potential +80 mV with a HEKA EPC-10 Double amplifier using PATCHMASTER
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software. Data were low-pass filtered at 5 kHz (4-pole Bessel, -3dB) and 
digitized to the computer at 20 kHz.
Amplitude distributions (Figure 3.1) were fitted with the sum of 2 Gaussian 
components. Dose-response data for peak responses in Figure 3.4 were fitted 
with the Hill equation:
y = ymaX/[1  + (EC50/A )n], (1)
where A is agonist concentration, EC50 is the concentration of agonist at which y 
= ymax/2, and n is the Hill coefficient. Values for simulated steady-state 
responses were obtained at 15 s following a simulated jump into ACh.
2.2.3 Model Fitting
Idealized records for patches that appeared to contain 1 channel were 
constructed using the segmental ^-means method (Qin, 2004), and fitted rate 
constants were obtained for models using a maximum likelihood algorithm (MIL) 
in QuB (Qin et al., 1996, 1997). Imposed dead times of 200 ^s provided the 
most reasonable lifetimes for state C3 as well as the fit of the probability density 
function (thick line in distributions). The number of components in closed and 
open duration distributions indicated that at least 5 closed states and two open
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states were needed to fit a full model that included desensitized states, which, 
prior to fitting, could not be assigned to particular gaps in the data record 
because of the low agonist concentration. The scheme shown in Model 1 was 
used to fit rate constants for 0.1 ^M, 1 ^M ACh and 1 ^M ACh + 1 ^M dFBr data, 
where A is the ACh concentration, k+1 and k+2 are association rate constants for 
binding of 1st and 2 nd ligand, and k-1 and k-2 are dissociation rate constants. 
Likewise, ko+2 governs the concentration dependent rate between O1 and O2, 
and ko-2 is the dissociation rate constant. 01 and P2 are opening rate constants 
for mono- and diliganded receptors, and a 1 and a2 are corresponding closing rate 
constants. Rate constants 61+/- and 62+/- govern transitions into and out of states 
D1 and D2, respectively.
2.2.4 Definition of Bursts
Single-channel recordings often contain several channel openings in 
succession (bursts) followed by long periods of closings that occur 
spontaneously. Analysis of bursts allows us to obtain information on how burst 
characteristics can be changed in the presence of a modulator as well as how 
accurate the model is. We use bursts to determine the accuracy of our model by 
comparing mean burst open time and mean burst length values obtained from 
the physical data to those computed by the model. If the values obtained from 
the model resemble those obtained from our data, then we have more
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confidence that the model is an accurate representation of the data. To do this 
we define bursts in the data with a critical value (tcrit) using the equation:
Am pr* e-Tcrit/Taul=Amp2* (1 -  e- Tcnt/Tau2)
Tcrit is the cutoff duration between exponential components and equalizes 
the area under the overlapping tails of the distributions. Where Amp1 and Amp2 
are the weights of the first and second components respectively for bursts. Tau1 
and tau2 are the time constants computed from MIL. Each tau in the distribution 
contributes one exponential component to the probability density function (thick 
line in distributions). Bursts that held doubles were discarded from the analysis, 
and values were compared to burst durations calculated from the model.
2.2.5 Calculation of Burst Parameters
We define bursts as a series of openings that occurs before ligand 
unbinds from the receptor. Burst parameters were calculated from transition 
probabilities (Colquhoun and Hawkes, 1982). Since ligand remains bound, a 
burst was defined as 1 or more openings consisting of transitions between O2 
and C3 only. The burst begins with an opening to O2 and ends with a transition 
to D2 or, alternatively, to C3 from which the receptor does not reopen (next 
transition to D1 or C2). O1 openings were not included due to the low occupancy
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of O1. To determine the distribution of the number of openings per burst, we 
calculated the probability that a burst contains 1, 2, 3,..., r openings. For a burst 
to consist of a single opening, the open channel must make a transition to C3 
followed directly by a transition to C2 or D1 (state 7 ^  state 3 ^  state 2 or state 
7 to state 3 ^  state 4; see state number assignments, Model 1). Alternatively, 
the open channel can desensitize to D2 (state 7 ^  to state 5) without entering 
C3. The probability that the burst consists of a single opening (P (1)) is therefore 
given by the sum of the probabilities of these events. P (1) = ^73-^32 + ^73 ^34 + 
TC75, where ^73=a2/(a2+62+), ro2=k-2/(k-2+P2+61+), ro4=61+/(61++k-2+P2), and
TC75=62+/(62++a2).
For the probability that the burst consists of two openings, P(2) =
TC73-TO7 -TC73-TO2 + tc73' TO7 ' tc73' TO4 + ^7 3 ^3 7 ^75. The probability of r openings is given 
by:
P(r ) = U73r • n37r-1 • (n 32 + n34) + n^ - 1  • n^ -1  • ^7 5  (6 )
Using the identities ro2 + ro4 = 1 -  ro7 and ^75 = 1- ^73, the expression can 
be simplified to the form for a geometric distribution:
P(r) = (^73 • ^37) r - 1  • (1 -  ^7 3  • ^ 37) (7)
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The mean number of openings per burst, mr = S “ = 1 ^ • P(r ), was calculated from 
the mean of the geometric distribution:
‘ (8 )1-n73'n37
The sum of the mean open time per burst [mr • m02, where m02 =
1/ ( a2 + 52+)j and the mean closed time per burst [(mr -  1) • mC3, where mC3 = 
1 /($2 + k - 2  + ^1+)j, gives the mean burst duration. The probability of being 
open during the burst was then calculated by dividing the mean open time per 
burst by the mean burst duration.
Model 1.
1 2  3 4
6 7 5
2.2.6 Estimation of Channel Open Probability
Estimates of the probability that each patch contained only a single 
channel were made using an approximation given by Colquhoun & Hawkes
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(Colquhoun and Hawkes, 1990). For N independent channels with two states 
(open and closed), the probability that, if one channel is open, the next transition 
will be closing of the open channel rather than opening of the second channel is 
given by:
1-Poven, , (2) 1 Popen/N
where Popen = m0/(m 0 + mc) (m0 and mc are the mean open time and mean 
closed time, respectively) is the probability that a channel is open on an observed 
record of single openings, and N is the number of channels in the patch. The 
probability of observing r consecutive single openings before the first double 
opening is P(r) = nr-1 (1 -  n). The probability of observing at least no 
consecutive single openings is then given by the cumulative form of the 
geometric distribution.
P(r > n0) = nn°-1. (3)
When channels exhibit long (desensitized) closed periods punctuated by 
bursts with high Popen, a better (more stringent) estimate of the probability of two 
channels is obtained by treating bursts as single openings (Colquhoun and 
Hawkes, 1990). We therefore adjusted n0 to reflect the number of bursts (n0/
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mr_exp,) by dividing the number of bursts by the openings per burst, where mr_exp 
is the experimentally determined number of openings per burst). mr_exp (no 
correction for missed events) was obtained in QuB by defining a tcrit separating 
components 1 and 2, or components 2 and 3 of closed duration distributions for 
experiments in ACh and ACh + dFBr, respectively. We defined the tcrit for dFBr 
as between 2 and 3 due to the components of 1 and 2 being extremely close to 
each other. Bursts were defined as runs of openings containing gaps less than 
tcrit. For the probabilities reported here as P (r > n0), r and n0 are bursts, not 
openings.
2.2.7 Simulations
All simulations shown for control (ACh model) and modulated (dFBr 
model) responses were made using rate constants from the best model of the set 
as determined by the total number of openings (> 1700, includes openings and 
closings) (see Table 1). A set was defined as patches that were obtained with 
the same ACh/dFBr concentration profile. Monte Carlo simulations of 
macroscopic currents in Figure 2.4A were made in QuB Express for 10,000 
channels with a unitary amplitude of 1 pA and standard deviation (SD) of 
Gaussian noise of 0.15 pA (Nicolai and Sachs, 2013). Current values were 
converted to and displayed as open probabilities (Popen) in Igor Pro 
(WaveMetrics).
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For a Markov process, the evolution of state occupancy probabilities is given by:
%  = Z}=1SjrJ i-Z}=1S i r iJ , (4)
where si is the fraction of channels in state Si , and rji and rij are the rate constants 
governing transitions into and out of state Si, respectively (Colquhoun and 
Hawkes, 1981). Given an initial condition of Pc 1=1 and a concentration profile 
c(t), which sets the values of concentration dependent rates, s (t) was integrated 
in xpp (v. 7.0, Bard Ermentrout; www.math.pitt.edu/~bard/xpp/xpp.html) using a 
Runge-Kutta method and 10 ^s time steps.
To examine trajectories of occupancy probabilities, simulations were 
driven by three different agonist concentration profiles: 1 ) a jump, 2 ) a slowly 
rising exponential function, and 3) a brief pulse of agonist given by an alpha 
function to mimic transmitter concentration at a fast synapse (x=500 ^s).
c(t) = A *  ( t / r ) *  e-(t-T)/T (5)
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2.3 Results
2.3.1 Conductance of LS Receptors
Channel openings with two distinct amplitudes were observed in cell- 
attached recordings with a low concentration of ACh (1 ^M). Figure 2.1A shows 
1 s records and corresponding open-point amplitude histograms for typical low- 
and high-amplitude channels recorded at -80 mV. Assuming a reversal potential 
of 0 mV, fitted histograms yielded chord conductance (g) estimates of 19.9+1.4 
pS (mean+SD; n=13 cells) and 28.6+2.5 pS (n=19 cells). Consistent with 
previous reports of inward rectification of a4p2 receptors (Buisson et al., 1996; 
Sabey et al., 1999), we did not observe LS receptor openings at assumed patch 
membrane potentials above 0 mV; however, I-V data collected between -80 and - 
20 mV for two patches (one in dFBr; Figure 2.1C, open circles) were well fitted by 
a linear equation, yielding a slope conductance estimate (30 pS) similar to our 
estimate of g, and a predicted reversal potential near 0 mV (-2.7 mV). Assuming 
inward currents rectify for depolarizations above -20 mV, our estimate of g may 
be somewhat high due to an underestimate of the driving force.
In patches that appeared to contain only one channel conductance, based 
on the observation of openings to only one level over a minimum recording 
period of 2.5 min, 71% (15 out of 21 patches) contained LS receptors.
Differences in apparent affinity for ACh for the two subtypes of a4p2 receptors 
(LS, a43p22 EC50 ~ 75 |j,M vs HS, a42023 EC50 ~ 1^M (Buisson and Bertrand,
2001; Nelson et al., 2003; Moroni et al., 2006)) favors activation of HS receptors;
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therefore, our data is consistent with reports that at least 70% of functional a4p2 
receptors expressed in HEK 293 cells are LS receptors (Li and Steinbach, 2010; 
Grupe et al., 2013). Modulation of LS receptor currents by dFBr could arise from 
effects on channel gating, unitary conductance, or recruitment of silent receptors 
(Fenster et al., 1999; Zhang and Steinbach, 2003; Li and Steinbach, 2010) (not 
investigated here). Fitting of open point amplitude histograms for ACh + dFBr 
(Figure 2.1B) yielded a mean conductance of 28.4+2.0 pS (mean+SD, n=12 
cells), similar to the value for ACh. Accordingly, dFBr does not modulate 
receptor function by altering single channel conductance. Sublevels were 
observed in patches with and without dFBr (Figure 2.1B, inset). Sublevels 
appeared more frequently dFBr; however, because they were brief and, even in 
dFBr, occurred too infrequently to analyze, they were fitted as full amplitude 
events.
2.3.2 Gating of LS Receptors in ACh and ACh + dFBr
Recordings in 1 ^M ACh or, alternatively, 1 ^M ACh + 1 ^M dFBr yielded 
3 patches for each condition (out of a total of ~ 150 patches containing LS 
receptors) that contained runs of 30 pS openings of sufficient length (> 250 
openings, average of 560) and no evidence of simultaneous openings of two 
channels. When the probability of a channel being open is low, as it was in our 
experiments (Popen ~ 0.01), more than one channel may be present despite the 
observation of openings to only one level (Colquhoun and Hawkes, 1990). We
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estimated the probability of obtaining the observed run of single openings 
(corrected for high Popen bursts, see Methods) for each patch if, in fact, two 
channels were present (see Methods). Values of P(r > n0) were 0.01, 0.23, and 
0.53 for ACh, and 0.03, 0.45, and 0.11 for ACh + dFBr. Figure 2.2 shows 50 s 
segments from ACh and dFBr patches with the lowest probability of having two 
channels.
In single-channel recordings it is often observed that several channel 
openings occur in rapid succession, where the individual openings are separated 
by brief closings (Colquhoun and Hawkes, 1982). Analyzing bursts allows all the 
openings within one burst to be attributed to a single channel, allowing shut 
periods within bursts to tell us about characteristics of a channel or the effects a 
modulator has on burst structure. Figure 2.3 shows burst length and open 
lifetime for 1^M ACh (A) and 1 ^M ACh + 1 ^M dFBr (B). Two exponentials were 
needed to fit the distributions of burst length and open time per burst. Burst 
length and open lifetime decrease in the presence of dFBr; the fast (if) and slow 
(is) time components decrease for burst length from 2 .8 6  ms to 1 .6  ms for if  and 
42.1 ms to 14.7 ms for is. Burst open lifetime distributions showed a similar 
trend, with if  being reduced from 3 to 0.75ms and is being reduced from ~16 to 
~11 ms. dFBr decreases the mean burst length and burst open lifetime, which is 
counter-intuitive to how a potentiator is expected to behave. The decrease in 
burst length is due to dFBr effectively reducing the intra-burst duration via 
decreasing the mean lifetime of desensitized state D1 (See 2.3.7), allowing 
greater simultaneous activation of receptors when exposed to agonist. Burst
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parameters for the patches, calculated for zero agonist concentration, were in 
agreement with the time constants obtained from the fitted burst distributions.
The calculated mean burst duration was 51.4 ms (42.1 ms from fits) and 25.7 ms 
(~15 ms from fits) for ACh and dFBr respectively. The calculated mean open 
time was also in agreement with values of 12.4 ms (~16 ms for the fits) and 8.1 
ms (~11 ms for the fits) in ACh and dFBr respectively. These results give us 
more confidence that our model is a fairly accurate representation of LS a4p2 
nAChR gating.
The stability of the patches for all concentrations (0.1 and 1 ^M) and in the 
presence of modulator (1 ^M ACh + 1 ^M dFBr) is shown in Figure 2.4. Popen 
was larger when calculated from the stability plots (0.1 ^M ACh: 0.13, 1 ^M ACh: 
0.16, and + dFBr: 0.14) due to the inclusion of periods of high occupancy.
2.3.3 Fitting Mechanisms to Single Channel Data
We investigated the mechanism of modulation for dFBr on a43022 nACh 
receptors by fitting a wide range of models directly to the single-channel data. 
Figure 2.5 shows models tested (left) along with the final model for 1 ^M ACh 
and 1 ^M ACh +1 ^M dFBr. Rates plus standard deviations (0.1 ^M and 1 ^M ± 
dFBr). Models on the left include Katz and Thesleff, Monod Wyman Changeux 
(MWC), modified MWC models that include desensitization and two models that 
did not contain activations steps, linear and star. All models were constrained by 
the requirement of microscopic reversibility for the cycle, while activation rates
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were not constrained. Due to the low probability of unliganded openings under 
our conditions these states were omitted from MWC and similar models.
More classical mechanisms such as the Katz and Thesleff and MWC 
models were initially utilized in order gain a better understanding of the data.
The Katz and Thesleff model fit the closed time distributions well for all 
concentrations and one open state fit the 1 ^M ACh data but not the 0.1 ^M data 
(Figure A.2.1). Activation rates are 10-fold higher for 1 ^M data than the 0.1 ^M 
data, whereas the concentration dependent rates of 2 k+2 and k+1 are 100 to 
1000x larger for the 0.1 ^M data than the 1 ^M data (Table A.2.1). Lifetime of C3 
is also extremely low and well below our dead time, giving less confidence in the 
rates leaving C3. The basic MWC model had similar problems in regards to the 
activation rates being 10 to 100 x larger for 0.1 ^M vs 1 ^M ACh data. Activation 
rates for the 1 ^M data set were low and gave low Popen in simulated 
macroscopic currents (not shown). The MWC model clearly showed that more 
than 3 closed states are required to fit the closed time distributions for our data. 
Recent work using concatenated receptors provides evidence that a43p22 
receptors possess two high affinity binding sites at a-p interfaces in addition to a 
3rd, high affinity site at the a-a interface (Harpsoe et al., 2011). Attempts to fit 
permutations of the MWC mechanism that included an additional agonist binding 
reaction always produced unreasonably large or small values for at least 1 rate 
constant. It may be that the additional activation step and subsequent open state 
have a lifetime very similar to that of either the mono or diliganded activation
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steps and open states in our data, thus we are unable to distinguish them from 
the other states.
2.3.4 Modified MWC Mechanisms
From the classical mechanisms we tested various scenarios of 
desensitization and its connections to the models. In order to improve fits, we 
added desensitized states to the MWC mechanism. The MWC modified 
mechanisms gave the most reliable results for all the cases we tested so we will 
focus on those mechanisms here. We tested various locations of two or more 
desensitized states. These included single desensitized states off of either O1, 
O2, or C3 (not discussed), two desensitized states off of O1/O2, O1/C3, or 
O2/C3, and a few variations with three desensitized states. Only a few of these 
variations are discussed in detail here. For these modified models two 
desensitized states or more gave better results in terms of fits to the closed 
distributions and reasonable simulated currents. For mechanisms that contained 
three desensitized states we excluded testing configurations that contained a D 
state off of O1. This is because any configuration that included a state off of O1 
resulted in a difference in the activation rates between concentrations, as well as 
dFBr not potentiating current when simulations were performed (data not shown), 
which does not agree with previous findings on dFBr’s apparent activity in whole 
cell experiments (Weltzin and Schulte, 2010). Desensitized states off of O1 and 
O2 gave decent fits (Figure A.2.3), but still had the issue of activation rates being
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10 to 100x higher for the 0.1 ^M data and the rates between O1 and O2 are high 
(Table A.2.3). It was found that a desensitized state was required off of state O2 
and off of C3 in order for the activation rates to agree with each other.
We further tested the existence of an additional desensitized state off of 
O2, leading to two desensitized states off of O2 and one off of C3. The fits to 
closed and open time distributions improved marginally with this addition and it 
was difficult to determine if an additional desensitized state was required from the 
fit alone (Figure A.2.4). With this configuration we saw a large discrepancy 
between the activation rates and rates entering O1 when comparing multiple 
concentrations of ligand (Table A.2.4). Simulated macroscopic currents also 
showed an increase in desensitization compared to the two desensitized state 
models.
The mechanism that gave us consistent activation rates as well as 
reasonable simulations for EC50 was a two desensitization state configuration 
with states off of O2 and C3. Consistent with reports in which 2 desensitized 
states were identified for LS a4p2 receptors (Sabey et al., 1999; Nelson et al., 
2003; Paradiso and Steinbach, 2003; Grupe et al., 2013). Rate constants from 
our two best patches (shown in Figure 2.2) that contained the largest number of 
events (ACh: 1754; ACh + dFBr: 1785), are shown in Table 2.1 were used for 
simulations. The average data from analysis of all 3 data sets in each condition 
are shown in Table 2.2.
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For the maximum likelihood fitting algorithm, model rate constants are 
adjusted to maximize the likelihood of the data (sequence and durations of 
openings and closings) with correction for missed events (Qin et al., 1996). 
Estimated rate constants for our model (Figure 2.5) yielded distributions of open 
and closed durations that agree with the observed data (Figure 2.6). A 
comparison of the data sets collected under each parameter (ACh and ACh + 
dFBr) indicated that rate constants for transitions to O1 (p1), from O1 to O2 (k+2) 
and transitions out of D1 and D2 (61- and 62-) were significantly larger in dFBr (P 
values: 0.061, 0.008, 0.001 and 0.047 for two-tailed t-test, respectively; Table 
2.2). For the fitted rate constants in Figure 2.5, the increase in 61- corresponds to 
a decrease in the mean lifetime of D1 (1/61-) from 77 ms to 7.6 ms, and the 
increase in 62- yields a reduction in the mean lifetime of D2 from 1.7 s to 493 ms.
2.3.5 Desensitization Based Mechanisms
At high concentrations of ACh almost all current can be attributed to the 
activity of diliganded AChRs (Elenes and Auerbach, 2002). The lifetimes of 
diliganded closed mouse AChRs (~10 ^s) are too brief to be detected 
(Maconochie and Steinbach, 1998). If concentrations are high enough, then the 
lifetimes of diliganded closed states are too brief to be detected. To account for 
this possibility are we fitted models that contained a doubly liganded open state 
and only desensitization like states for closed states. We made two 
desensitization based models, linear and star. For the linear and the star models 
the fits are relatively good for closed time distributions, but open time
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distributions for 0.1 ^M and 1 ^M ACh +1 ^M dFBr requires more than one open 
state (Figure A.2.5 and A.2.6). Majority of rates agreed in the models between 
concentrations. The exceptions were for linear k23 and k21, and for star kO4, k3O, 
and k1O (Table A.2.5 and A.2.6). Simulations testing the decay time course for 
these models (starting in state O) revealed dFBr increased the decay time 
course, which does not coincide with previous reports on the effects of dFBr (Kim 
et al., 2007; Weltzin and Schulte, 2015). It is not surprising that these schemes 
failed to describe open-time distributions that clearly contain more than one open 
component. Also, if our data did not contain any information on activation, then 
we would see a strong case for dFBr as a potentiator that destabilizes 
desensitized states in models that lack activation rates. We are confident that 
the concentrations utilized in the low-sensitivity experiments are low enough to 
allow the observation of activation kinetics for the a4p2 LS subtype.
2.3.6 Simulations of Macroscopic Currents
To determine if our estimated kinetic parameters supported potentiation 
over a range of ACh concentrations, we simulated macroscopic responses to 
concentration jumps (Figure 2.7A). Potentiation of the peak response by dFBr 
was apparent at 10 ^M ACh, less at 100 ^M, and negligible at 1 mM ACh where 
the peak open probability for ACh alone was ~ 0.8. At concentrations of ACh 
above 1 mM, peak responses were inhibited in dFBr (Figure 2.7B). dFBr yielded 
3-3.5-fold potentiation of desensitized (near steady-state) responses, as
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expected for shorter lifetimes of desensitized states. Fitted Hill equations to peak 
responses yielded (mean+SD) EC50 values and Hill slopes of 58+4 ^M and 
0.76+0.04 for ACh, and 17+1 ^M and 0.98+0.05 for dFBr. The concentration 
dependence of dFBr-induced differences (increases) in responses are shown for 
ACh concentrations up to 1 mM in Figure 2.7C. Our model yielded a maximal 
Popen of ~ 0.9, consistent with an estimate from noise analysis for LS receptors of 
> 0.8 (Li and Steinbach, 2010).
When driven with a jump into 1 mM ACh, desensitization exhibited a 
biphasic, exponential decay with a time constant of 55 ms for the fast, major 
amplitude component (relative amplitude 0.33) and 220 ms for the slow 
component (Figure 2.7A). The fitted, steady-state value was 0.07, with steady- 
state values of Popen for all concentrations (assessed from mean response 
amplitudes near the end of a 15 s jump) are shown in Figure 2.7B (open 
squares).
2.3.7 Occupancy Probabilities and Desensitization
An advantage of single-channel methods for studies of mechanism is that 
once the rate constants for the model are determined, the time-dependent 
probability of occupancy of each state can be determined for any concentration 
profile. One aim of examining occupancy probabilities was to determine how 
changes in occupancy of D1 and D2 contribute to potentiation. Figure 2.8 shows 
occupancy probabilities for concentration jumps into 10 ^M, 100 ^M, and 1 mM
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ACh. The open probability was approximated by Po2 (Po1 is less than 0.005 for 
all simulations). For jumps into a low concentration of ACh (10 ^M), dFBr 
increased the peak response by a factor of 2 (Po2_ACh = 0.13, Po2_dFBr = 0.26).
During the early phase of macroscopic desensitization (right panels Figure 
2.8), the reduction in Pd1 by dFBr was the significant contributor to potentiation. 
Even though entry into D1 occurs earlier, PD1_dFBr is lower and drops faster 
compare to that of PD1_ACh. Potentiation is almost entirely due to destabilization 
of D1. This is most notable at larger concentrations and appears to be negligible 
at concentrations of ~1 ^M. As P02 approaches steady-state (best seen for 1 
mM simulation, lower panels), the difference between PD1_ACh and PD1_dFBr 
declines due to the relatively slow relaxation of ACh model receptors from D1 
into D2. Steady-state differences in P02 arise almost entirely from destabilization 
of D2. The early versus late contribution of destabilization of D1 and D2 are also 
seen for higher concentration simulations, where the fraction of bound receptors 
are close to 1 shortly after P02 reaches the peak.
2.3.8 Slow Solution Exchange and Potentiation
In a recent study in which a43022 receptors were in excess, 3-fold 
potentiation was observed for 1 ^M dFBr with 100 ^M ACh (EC75 for that 
preparation) (Weltzin and Schulte, 2015). Our models yielded a prediction of 
less than 1.1-fold potentiation at EC75 (~ 300 ^M) because of the high Popen (~ 
0.68) at the peak response to ACh alone. Differences between oocyte results
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and model predictions could arise from different gating properties of LS receptors 
in HEK cells, recruitment of receptors from a large population of nonfunctional, 
silent receptors (Fenster et al., 1999; Zhang and Steinbach, 2003; Li and 
Steinbach, 2010), or from a relatively slow activation profile in oocytes due to 
slow solution exchange (Joshi et al., 2004). To determine if slow solution 
exchange predicted larger potentiation, we calculated occupancy probabilities 
using an exponential function for the concentration profile c(t) = cmax * (1 -  exp 
(-t/xc)) (Figure 2.9). A time constant (xc) of 4 s yielded a time to peak of ~ 400 ms 
(ACh model) for 300 ^M ACh, similar to published results for a4p2 responses in 
oocytes (Kim et al., 2007; Weltzin and Schulte, 2010). A 400 ms rise time is also 
expected for the vertical flow exchange apparatus used in those experiments 
(Joshi et al., 2004). Figure 2.9A shows that a slow rise in ACh concentration 
yielded a lower peak Popen for the naive receptor and a large increase in 
response (1.64-fold) compared to jumps (lower panel).
2.3.9 Deactivation Following a Pulse of High Agonist Concentration
To examine macroscopic responses to an agonist concentration profile 
typical of fast synapses (Clements et al., 1992; Silver et al., 1996; Beato, 2008), 
we drove models with an alpha function with peak concentration of 1 mM and 
half maximum width of 1.2 ms (Figure 2.10). The peak open probability for the 
ACh model (Po2_ACh = 0.28) was low in comparison to that found for sustained 
jumps into the same concentration of ACh. dFBr yielded a 1.6-fold increase in
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response amplitude (Po2_dFBr = 0.45) due to an increase in the fraction of bound 
receptors. For the ACh model, the decay of P02 (deactivation) exhibited a fast, 
major amplitude (0.72) phase with a time constant of 44 ms, in addition to two 
smaller, slow components with time constants of 133 ms and 5.4 s. The slow 
time constants matched time constants describing relaxation of Pd1 and Pd2, 
consistent with the view that the time course of LS receptor deactivation reflects 
a fast phase of channel closing followed by delayed openings arising from 
receptors leaving D1 and D2.
In single channel recordings of a7 nAChRs, individual openings were 
found to terminate not by channel closing, but by entry into desensitized states 
(daCosta et al., 2011) (see also, (Marabelli et al., 2015)). For the LS receptor, 
relaxation of receptors into D1 and D2 exhibited a time course similar to the fast 
decay of P02 (Figure 2.10A) indicating that bursts of openings may terminate in 
D1 or D2. To test the hypothesis that the initial phase of deactivation is 
accelerated by entry into desensitized states, responses were simulated with 61+ 
and 62+ set to zero. The inset shows that the mean decay time of P02 was 
prolonged ~ 3-fold (x=157 ms). The deactivation time course of LS receptors 
was therefore not a simple reflection of channel closing.
For the dFBr model, the decay of P02 was fitted with the sum of two 
exponential components. The time constant of the major amplitude (A1=0.97), 
fast phase (45 ms) was slightly faster than the value found for naive receptors, 
and the time course of the slow phase (x2=649 ms) was similar to the time course
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of decay of Pd2 (x=653 ms). A decay component for P02 reflecting recovery of 
receptors from D1 was not observed because the fast time constant for 
relaxation of Pd1 (x1 = 76 ms; A1 = 0.97) was the same as the fast time constant 
for P0 2 . Pd1 is scaled in Figure 2.11B to show this relationship. Despite the fact 
that deactivation was faster in dFBr, charge transfer at 100 ms was still 1.4-fold 
larger. In contrast to naive receptors, removal of desensitization for the dFBr 
model only produced a small increase in the time constant (x=50 ms) of a single 
exponential fit to the decay of P02 (inset). With only 61 + set to zero (trace not 
shown), the time constant was slightly shorter (x=39 ms); therefore, elimination of 
D1 offsets the effect of removing D2. The calculated mean burst duration in dFBr 
was 26 ms (Popen=0.98, mr=3.1) with desensitization, so a functional burst in dFBr 
includes, on average, ~1 sojourn in D1. When burst Popen is high, the mean burst 
duration is a good approximation of the time constant fitted to the decay of 
aligned bursts (no latency to first opening). Removal of desensitization increased 
the mean burst duration from 51 ms (Popen=0.98, m-=4.1) to 154 ms (Popen=0.98, 
mr=8.5).
The development of and recovery from desensitization following a pulse of 
agonist concentration was faster in dFBr (Figure 2.11). dFBr decreased the time 
to peak of Pd1 + Pd2 from 187 ms to 69 ms. Recovery from desensitization 
reflected recovery of both Pd1 and Pd2 for ACh and Pd2 only for dFBr. Despite 
the fact that receptors were only exposed to saturating agonist for ~1 ms, 54% of 
naive receptors bound by agonist were desensitized. In dFBr, only 18% were 
desensitized.
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2.4 Discussion
Studies of a4p2 receptors in whole cells are complicated by expression of 
two subtypes of receptors (Nelson et al., 2003; Moroni et al., 2006). With 
oocytes, the ratio of injected RNAs can be altered to favor one subtype (Nelson 
et al., 2003; Moroni et al., 2006; Weltzin and Schulte, 2015); however, for studies 
of fast receptors, cell lines are often preferable because solution exchange times 
are shorter for small cells. When a4p2 receptors are expressed in HEK293 cells, 
most of the functional surface receptors are the low-sensitivity (a43022) subtype 
(Nelson et al., 2003; Li and Steinbach, 2010), and this preparation has been 
used successfully to characterize macroscopic properties of LS receptors and, 
recently, to investigate mechanism for the LS-selective modulator NS9283 
(Grupe et al., 2013). Unfortunately, dFBr potentiates both subtypes (Weltzin and 
Schulte, 2015) so, for us, a single-channel approach provided the most 
straightforward option for circumventing problems with heterogeneity, with the 
added benefit of gaining greater insight into mechanism. If full gating models can 
be obtained (or at least ones that give a fairly complete representation of 
function), as we did here for naive and modulated receptors, simulations of 
macroscopic responses can be made for any profile of agonist concentration.
This could prove useful for predicting the consequences of dFBr modulation for 
signaling at LS receptors because receptors may experience quite different 
profiles in ACh concentration due to different spatial relationships between 
receptors and release sites (Descarries et al., 1997; Ren et al., 2011) and, as we
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suggest here, the change in the postsynaptic signal may depend on the 
concentration profile, with larger effects for profiles that favor desensitization.
The model for the naive receptor presented in this study generated 
predictions for macroscopic behavior that agree with results for human LS 
receptors from other studies. Our finding of two desensitized states with short 
and long lifetimes is supported by observations of two phases of current decay in 
concentration jump experiments (Nelson et al., 2003; Paradiso and Steinbach, 
2003; Grupe et al., 2013), and also by experiments documenting corresponding 
fast and slow phases for recovery of receptors from desensitization (Paradiso 
and Steinbach, 2003; Grupe et al., 2013). Except perhaps for the slow the time 
course of desensitization recovery (discussed below), the values of time 
constants (of fitted exponentials) reported by other groups agree with our values 
(Nelson et al., 2003; Grupe et al., 2013). The fitted rate constants for our model 
also yielded expected values for potency and Hill coefficients (Nelson et al.,
2003; Moroni et al., 2006; Grupe et al., 2013). Ideally, we would like to perform 
additional experiments with a range of ACh + dFBr concentrations to verify if the 
potentiation exhibited by dFBr on a single-channel level depends on agonist 
concentration. Overall, the model does a remarkably good job of replicating high 
concentration results.
The primary finding of this study was that dFBr decreased the mean 
lifetimes of two desensitized states. Our conclusions, and the validity of our 
models, depend on obtaining correct estimates for the lifetimes of C1, D1, and 
D2, the longest closed durations in our single-channel records and, therefore, the
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most susceptible to underestimation due to the possibility that patches contained 
multiple channels. For the patches used to fit rate constants for simulations, we 
found low values (<0.05) for the estimates of the probability that a second 
channel is present [P (r > n0)]; however, the estimates for P(2) channels were 
larger for other patches. Moreover, if a second channel were active for only part 
of the record, P (r > n0) is less reliable. D2 is isolated from other closed states 
and has a long mean lifetime (1.7 s); therefore, if undetected channels were 
present, the value of 62- should be correlated with P (r > n0). Regression analysis 
showed that P (r > n0) and (normalized) 62- were not correlated (Pearson r  = - 
0.29, P(r) = 0.57). The finding of shorter lifetimes of D1 and D2 in dFBr appears 
to be well supported; however, we are less certain about the precise values of 62- 
and k+1. For rat a4p2 receptors activated by ACh, the reported slow time 
constant for recovery from desensitization was 17 s (Paradiso and Steinbach, 
2003). In a recent study of human, mostly LS receptors expressed in HEK 293 
cells, the slow phase of recovery was 12.8 s (Grupe et al., 2013). In simulations 
(not shown), decreasing the value of 62- from 0.6 s-1 to 0.2 s-1 (a value well within 
the error reported for group data) prolonged the slow recovery time constant from 
5 s to 10 s, and decreased the steady-state Popen from 0.05 to 0.025. Effects on 
other macroscopic parameters were negligible. Additional studies are needed to 
obtain better estimates of 62- and k+1.
Our findings have potential implications for signaling. First, in cases 
where receptors are subject to a prolonged elevation in transmitter concentration 
(Descarries et al., 1997; Zoli, 1999; Ren et al., 2011), destabilization of
61
desensitized states would result in a substantial increase in charge transfer. 
Interestingly, dFBr had no effect on response amplitude for agonist 
concentrations below 1^M, so the possibility exists for functional selectivity based 
on a threshold of agonist concentration.
At fast synapses, for which low-sensitivity receptors are better suited 
(Nelson et al., 2003), receptors are exposed to a brief concentration and are far 
from steady state. Our results predict a steep dependence of receptor 
occupancy on transmitter concentration. For glutamatergic synapses, estimates 
of the time constants for the decay of transmitter range from 1.2 to 4 ms 
(Clements et al., 1992; Diamond and Jahr, 1995). For our model, increasing the 
duration of the pulse of 1 mM ACh from 1 ms to 4 ms increased the estimated 
Popen from 0.25 to 0.68. From the perspective of development of positive 
allosteric ligands, if receptors are saturated at fast cholinergic synapses, dFBr 
and other compounds that exhibit potentiation by scaling the current, will be 
relatively ineffective at boosting postsynaptic signals that arise from low 
frequency inputs. Compounds that enhance charge transfer by prolonging 
deactivation may be more effective, e.g. NS9283 (Grupe et al., 2013). For high 
frequency stimuli, compounds that accelerate recovery from desensitization may 
be preferable.
Paradiso and Steinbach showed that prolonged application of ACh 
promotes entry into a desensitized state that recovers slowly; the relative 
amplitude of the slowly recovering component of desensitization increased with 
longer jumps into agonist (Paradiso and Steinbach, 2003). Our results do not
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fully account for their observations, which suggest the existence of a third 
desensitized state; however, we do observe a redistribution of receptors from D1 
to D2 at longer times (x ~ 1 s). For experiments in which desensitized receptors 
were found to be reactivated by dFBr (Weltzin and Schulte, 2010), the only 
mechanism that, for our model, can account for their observed rapid increase in 
the fraction of open receptors is via an increase in the rate out of D2. Our results 
do not support the large increases in peak current with high agonist 
concentrations found in oocyte experiments (Kim et al., 2007; Weltzin and 
Schulte, 2015); however, at least part of the discrepancy is likely due to slow 
solution exchange, which allows time for desensitization to develop.
In conclusion, we provide the first model for gating of human a43022 
receptors from single channel data. We provide evidence favoring the view that 
the allosteric modulator dFBr improves LS receptor responsiveness by 
destabilization of desensitized states. The consequences of modulation for 
signaling will likely depend on the frequency and profile of agonist concentration 
at the receptors.
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Figure 2.1A: Unitary conductance’s of a4p2 receptors. (A) Sample traces and 
open point amplitude histograms are shown for low [21.0+1.9 pS (mean+SD); HS 
receptor; gray traces] and high [30.6+3.3 pS (mean+SD); LS receptor; black 
traces] conductance channels recorded in 1 ^M ACh.
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Figure 2.1B: Unitary conductance’s of a4p2 receptors. (B) Fitted amplitude
histograms and traces are shown for an LS receptor in 1 ACh [33.5+3.9 pS
(mean+SD)] and a receptor in 1 ^M ACh and 1 ^M dFBr [32.3+5.1 pS
(mean+SD)]. Inset shows example of occasional sublevel [dotted line at 1.38 pA
(17.3 pS)] primarily seen in dFBr.
Amplitude (pA)
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Figure 2.1C: Unitary conductance’s of a4p2 receptors. (C) I-V plot shows mean 
values (+ SD) of HS (19.9+1.4 pS; n=13 cells; gray star) and LS (28.6+2.5 pS; 
n=19 cells; black circle, obscured) receptors recorded in 1 ^M ACh and LS 
receptors in 1 ^M ACh + 1 ^M dFBr (28.4+2.0 pS; n=12 cells; blue square). 
Additional I-V data fitted with linear equations yielded slopes of ~30 pS and 
extrapolated reversal potentials near -3 mV
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Figure 2.2: Steady-state recordings of a43022 receptors. Recordings shown are 
for 1 ^M ACh (top) or 1 ^M ACh + 1 ^M dFBr (bottom). Contiguous traces 
represent 50 s of data filtered at 1 kHz (-3 dB, 4-pole Bessel).
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Figure 2.3: Burst characteristics for a43022 receptors. Distributions are fitted 
with two exponentials for 1 ^M ACh (red; tcrit: 1.22 ms) and 1 ^M ACh + 1 ^M 
dFBr (blue; tcrit: 1.99 ms). Determination of critical time is described in methods. 
Distributions are plotted up to 140 ms for burst Length and 100 ms for burst open 
lifetime for comparison between control and dFBr. (A) Distributions for 1 ^M 
ACh burst length (left; n : 2.86ms, 12: 42.1 ms) and burst open lifetime (right; n: 
3.0 ms, 12: 15.9 ms). (B) Distribution for 1 ^M ACh + 1 ^M dFBr burst length 
(left; n: 1.6 ms, 12: 14.7 ms) and burst open lifetime (right; n : 0.75 ms, 12: 10.9 
ms). The presence of dFBr decreases burst length and open lifetime fast and 
slow time components.
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Figure 2.4: Stability plots for a43022 receptors. Stability plots obtained from QuB
(50 events per segment, overlap of 25 events) for 0.1 (top) and 1 ^M ACh
(middle) and 1 ^M ACh 1 ^M dFBr are displayed as segment vs occupancy of
opening. An event is composed of either an opening or a closing. All patches
are relatively stable with intermittent spikes in occupancy.
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Figure 2.5: Models tested on a43022 receptors. Left: Examples of models 
tested, included are activation based mechanisms (from top) Katz and Thesleff, 
MWC, MWC with 2 desensitized, MWC with 3 desensitized and the 
desensitization models linear, and star. Right: Final model utilized with rate 
constants. Rate constants governing transitions C2^O1, O1^O2 and out of 
desensitized states D1 and D2 (circled) were significantly larger (P < 0.05) in 
dFBr.
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Figure 2.6: Gating models for naive and modulated LS a4p2 receptors. Open 
and closed duration distributions from patches shown in Figure 2.2 for 0.1 ^M 
ACh (top), 1 ^M ACh (middle) and 1 ^M ACh + 1 ^M dFBr fitted with the gating 
model shown in Figure 2.5.
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AFigure 2.7A: Concentration dependence of potentiation of peak and steady-state 
currents. (A) Simulated currents are shown for the ACh (black traces) and dFBr (blue 
traces) models driven by 5 s jumps into 10 ^M (top), 100 ^M (middle), and 1 mM 
(bottom) ACh. Exponential functions fitted to the decay phase of currents for 1 mM ACh 
traces are superimposed (black traces). ACh model: A1= 0.33, n  = 55 ms, A2=0.45, 
12=220 ms, y0= 0.07. dFBr model: x=157 ms, y0=0.26. Rise times (10 -  90%) for ACh 
and dFBr models with 1 mM ACh were 9.2 ms and 7.5 ms, respectively. Calibration 
bar: units of open probability (Popen).
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Figure 2.7B: Concentration dependence of potentiation of peak and steady-state 
currents. (B) The channel open probability (Popen) of peak (stars) and steady-state 
(squares) responses are plotted for ACh (black) and dFBr (blue) models as a function of 
ACh concentration (1, 2.15, 4.64, 10, 21.5, 46.4, 100, 215, 464, 1000, 2150, 4640, and 
10000 ^M). The maximal (peak) Popen for saturating ACh concentration was ~ 0.92 for 
ACh and 0.81 for dFBr. Slope and EC50 values from fitted Hill equations were 
0.76+0.04 and 58+3.6 ^M for ACh, and 0.98+0.05 and 17+1. 1 ^M for dFBr.
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Figure 2.7C: Concentration dependence of potentiation of peak and steady-state 
currents. (C) The ratio of dFBr model to ACh model Popen is shown as a function of 
ACh concentration. Potentiation of peak response (stars) was largest at low ACh 
(101% increase for 4.64 ^M ACh) and declined to zero at 1 mM ACh. At concentrations 
higher than 1mM, dFBr responses were smaller (shown in B). Steady-state, 
desensitized responses (blue squares) were potentiated 3-3.5-fold above 10 ^M ACh.
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Figure 2.8: Occupancy probabilities using a concentration jump profile for a43022 
receptors. See caption on next page.
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Figure 2.8: Occupancy probabilities using a concentration jump profile for a43022 
receptors. Occupancy probabilities (y-axis) of channel states following a concentration 
jump are shown for 10 (top), 100 (middle), and 1000 (bottom) ^M ACh for ACh (solid 
lines) and dFBr models (dashed lines). The maximum probability of occupancy of O1 
was low (< 0.005) and changes in Po1 with dFBr were negligible; therefore, Po2 was 
used as an estimate of open probability. Occupancy probabilities of states C2 and C3 
were also low, except for the first few milliseconds of the high concentration simulation 
where Pc3 reached ~ 0.1 in dFBr.
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Figure 2.9A: Slowly rising concentration profile decreases peak Popen and increases 
potentiation with dFBr. (A) Occupancy probabilities are shown for a slow, exponential 
rise in ACh concentration according to: c(t) = A * (1 -  exp(- t / r ) )  where A = 300 ^M 
(EC75) and x = 4 s.
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Figure 2.9B: Slowly rising concentration profile decreases peak Popen and increases 
potentiation with dFBr. (B) Response to step increase in ACh concentration to 300 ^M.
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Figure 2.10A: Response to a pulse of a high concentration of agonist. Occupancy 
probabilities are shown for models driven by an alpha function to mimic a synaptic 
agonist concentration profile. (A) Responses are shown for the ACh model. Peak 
open probability (Po2) was 0.28 at 3.7 ms compared with 0.45 at 3.6 ms for dFBr 
(shown in B; 1.61-fold potentiation). The decay of P02 was fitted with the sum of 3 
exponentials (A1=0.72, n=44 ms, A2=0.27, i 2=133 ms, A3= 0.012, i 3=5.4 s, y0= 0). The 
decay of Pd1 was fitted with two exponential components (A1=0.98, n=147 ms, A2=0.02, 
12=5.0 s, y0=0), and Pd2 was fitted with one component (x=5.2 s, y0=0). Main inset 
shows P02 for the ACh model (black trace) with P02 for a modified model (blue trace) in 
which rates into desensitized states D1 and D2 were set to zero (61+ = 62+ = 0). The
decay time constant for the fitted exponential was 157 ms (y0=0).
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Figure 2.10B: Response to a pulse of a high concentration of agonist. (B) For the 
dFBr model the decay of Po2 was fitted with two exponential components (A1=0.97 
n=45 ms, A2=0.02, t2=649 ms, y0=0). Pd1 was fitted with two components (A1=0.97, 
n=76 ms, A2=0.03, t2=556 ms, y0=0), and Pd2 was fitted with a single exponential 
(x=653 ms, y0=0). For dFBr, the inset shows that removal of desensitization had a 
negligible effect on the decay time course. The time constant (x=50 ms; y0=0) was 
similar to the time constant for the fast, major component of decay of Po2 with 
desensitization intact (x=46 ms).
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Figure 2.11A: Development and recovery from desensitized states following a brief 
pulse of agonist concentration. Responses are shown for the same alpha function 
pulse in Figure 2.10. The fraction of occupied receptors (1-Pci) is nominally the same 
as the sum of receptors in O2, D1, and D2 (Po2+di+d2) for both models. Insets show 
responses on expanded time scales. (A) For the ACh model, desensitization (Pdi + D2) 
peaked at 197 ms. Relaxation of Pdi + D2 was fitted with the sum of two exponentials 
with time constants (Ai=0.07, n=200 ms, A2=0.93, i2=5.2 s, y0=0) similar to relaxation 
time constants for the components Pdi and Pd2 fitted individually.
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Figure 2.11B: Development and recovery from desensitized states following a brief 
pulse of agonist concentration. (B) For dFBr, Pd1 + D2 peaked at 69 ms, and relaxation 
of Pd1 + D2 was well fitted with a single exponential with a time constant (x=654 ms) 
identical to that for that for Pd1 alone (Figure 2.10).
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Table 2.1. Rate constants used in simulations for 0,43022 receptors. Errors are the 
relative estimated error in the fits.
Rate
Constant
Units 1 juM ACh (+) dFBr
k+i M-1s-1 3E5 ±23% 6.2E5 ±7.8%
k-i s-1 377 ±32% 480 ±8.9%
k+2 M-1s-1 1.4E8 ±31% 1.9E8 ±18%
k-2 s-1 464 ±19% 751 ±1.7%
Pi s-1 99 ±38% 1009 ±9.5%
0 1 s-1 351 ±22% 1088 ±6.6%
Sl + s-1 246 ±18% 703 ±15%
Si- s-1 13±30% 131 ±15%
p2 s-1 3456 ±6% 3606 ±15%
02 s-1 76 ±5% 119 ±10%
52+ s-1 7.4 ±21% 5.3 ±27%
52- s-1 0.6 ±24% 2.0 ±31%
ko+2 M-1s-1 227 2096
ko-2 s-1 3.6E-6 1.9E5
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Table 2.2. Mean values for 043022 receptor rate constants. Errors are the standard
deviations between the three patches.
Rate
Constant
Rate 0.1 uM ACh 1 uM ACh 1 uM ACh + 
1 uM dFBr
mean
(n=2)
SD mean
(n=3)
SD mean
(n=3)
SD P
k+i M-1s-1 3.1E5 3.1E3 3E5 5.8E3 3.3E5 2.5E5 0.85
k-i s-1 20 16 206 176 378 193 0.32
k+2 M-1s-1 6E8 3E8 1E8 4.5E7 2.8E8 2.4E8 0.28
k-2 s-1 521 256 557 323 794 287 0.39
Pi s-1 28 5.3 46 48 679 421 0.06
01 s-1 2316 49 536 293 884 333 0.25
Si+ s-1 464 71 171 68 967 642 0.10
Si- s-1 3.9 1.1 9.5 5.3 149 29 0.001
p2 s-1 2081 1028 3872 984 2867 640 0.21
02 s-1 75 7 110 82 131 43 0.72
52+ s-1 6 1.4 7 0.3 8.7 4.4 0.36
52- s-1 0.34 0.07 0.31 0.26 1.4 0.6 0.046
kO+2 M-1s-1 593 521 579 350 2075 385 0.01
kO-2 s-1 2.2E-6 7E-7 9.5E-5 1.5E-4 1E-4 0.9E-4 0.93
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Appendix
Figure A.2.1: LS Katz and Thesleff model fits. Open and closed duration distributions 
from patches for 0.1 uM (top) and 1 uM ACh (bottom) group fitted with gating model 
Katz and Thesleff shown in Figure 2.5.
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wFigure A.2.2: LS MWC model fits. Open and closed duration distributions from patches 
for 0.1 ^M (top) and 1 ^M ACh (bottom) group fitted with gating model MWC shown in 
Figure 2.5.
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tFigure A.2.3: LS modified MWC model fits. Open and closed duration distributions 
from patches for 0.1 ^M (top) and 1 ^M ACh (bottom) group fitted with gating model 
modified from classical MWC mechanism shown in Figure 2.5 (third from the top). 
Model is modified to contain two desensitized states off of the mono and di-liganded 
open states.
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Figure A.2.4: LS modified MWC model fits with three desensitized states. Open and 
closed duration distributions from patches for 0.1 ^M (top) and 1 ^M ACh (bottom) 
group fitted with gating model modified from classical MWC mechanism shown in Figure
2.5 (fourth from the top). Model is modified to contain three desensitized states. One 
off of the doubly liganded closed state and an additional two off of the di-liganded open 
states.
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Figure A.2.5: LS linear model fits. Open and closed duration distributions from patches 
for 0.1 ^M (top) and 1 ^M ACh (bottom) group fitted with gating model lacking activation 
and containing 5 desensitized states shown in Figure 2.5 (fifth from the top). Model 
lacks activation and effectively begins in the doubly liganded open state. This model 
assumes that we are not seeing any activation rates in our data.
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Figure A.2.6: LS star model fits. Open and closed duration distributions from patches for 
0.1 ^M (top) and 1 ^M ACh (bottom) group fitted with gating model lacking activation 
and containing 5 desensitized states in a star shape shown in Figure 2.5 (bottom).
Model lacks activation and effectively begins in the doubly liganded open state.
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Table A.2.1: Rate constants for Katz and Thesleff mechanism.
T a b l e  A . 2 . 1
R a t e  C o n s t a n t U n i t 0 . 1  ju M 1 u M
2 k + 1 M-1s-1 1.6E6 ± 44% 1E9 ± 37%
k +1 M-1s-1 8.7E8 ± 38% 2.2E9 ± 61%
12 s-1 547 ± 29% 1485 ± 89%
k-1 s-1 1 6 ± 100% 947 ± 99%
P 1 s-1 2360 ± 29% 2420 ± 63%
(C1 s-1 67 ± 27% 919 ± 99%
2 k + 2 M-1s-1 1.2E9 ± 98% 2.3E6 ± 75%
k +2 M-1s-1 1.1E7 ± 41% 0.14 ± 100%
2 k -2 s-1 1.5 ± 41% 5E-8 ± 100%
k -2 s-1 0.83 ± 46% 0.88 ± 77%
d +1 s-1 20 ± 29% 4.4 ± 93%
d -1 s-1 3.7 ± 29% 0.08 ± 70%
d +2 s-1 9E-4 ± 65% 94 ± 70%
d -2 s-1 0.3 ± 99% 10.5 ± 71%
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Table A.2.2: Rate constants for MWC mechanism.
T a b l e  A . 2 . 2
R a t e  C o n s t a n t U n i t 0.1 juM 1 uM
2k+i M-1s1c-1 9.5E6 ± 15% 4E5 ± 19%
k + i M-1s1c-1 1.8E8 ± 99% 3.2E6 ± 97%
2k- - 896 ± 55% 707 ± 95%
5 ± 99% 5 ± 98%
P i 66 ± 55% 74 ± 93%
a i 1106 ± 50% 349 ± 97%
p 2 2060 ± 55% 2640 ± 94%
a 2 77 ± 45% 78 ± 92%
k + 2 M-1s-1 6.9E2 ± 99% 138± 44%
k-2 7.9e-6 ± 56% 1.9E-6 ± 53%
s
s
s
s
s
s
1s
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Table A.2.3: Rate constants for a MWC modified mechanism
c '  ‘o l'o ic
T a b l e  A . 2 . 3
R a t e  C o n s t a n t U n i t 0 . i  juM i  u M
2 k + i M-1s-1 4.6E8 ± 24% 1.1E7 ± 24%
k + i M-1s-1 4E9 ± 39% 2.1E7 ± 99%
2 k - i s-1 1208 ± 34% 43 ± 98%
k - i s-1 603 ± 30% 404 ± 19%
P i s-1 681 ± 30% 560 ± 90%
a i s-1 272 ± 18% 86 ± 69%
p 2 s-1 4360 ± 18% 4640 ±68%
a 2 s-1 61 ± 18% 76 ± 68%
k +2 M-1s-1 2E9 ± 29% 2.4E8 ± 73%
k -2 s-1 21 ± 32% 53 ± 71%
d + i s-1 151 ± 21% 68 ± 26%
d - i s-1 1 ± 21% 0.2 ± 9.5%
d + 2 s-1 2 ± 50% 1 ± 69%
d - 2 s-1 0.12 ± 33% 0.04 ± 42%
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Table A.2.4: Rate constants for a three desensitized state MWC mechanism.
T a b l e  A . 2 . 4
R a t e  C o n s t a n t U n i t 0 . i  juM i  u M
2 k + i M-1s-1 1.05E9 ± 36% 3.1E7 ± 32%
k + i M-1s-1 3.7E9 ± 85% 3.8E8 ± 33%
2 k - i s-1 758 ± 85% 419 ± 50%
k - i s-1 296 ± 22% 350 ± 99%
P i s-1 0.001 ± 99% 74 ± 73%
a i s-1 9.8e-5 ± 99% 855 ± 55%
p 2 s-1 2710 ± 81% 3570 ± 43%
a 2 s-1 315 ± 82% 79 ±44%
k +2 M-1s-1 1E9 ± 81% 2E4 ± 99%
k -2 s-1 279 ± 83% 4E-5 ± 99%
d + i s-1 44 ± 23% 82 ± 18%
d - i s-1 4.5 ± 25% 0.14 ± 19%
d +2 s-1 6.8 ± 91% 0.59 ± 99%
d -2 s-1 0.11 ± 54% 0.003 ± 66%
d +3 s-1 262 ± 25% 332 ± 20.5%
d -3 s-1 0.69 ± 43% 96 ± 1 %
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Table A.2.5: Rate constants for a linear mechanism.
0^cic4c4c4c
Table A.2.5
Rate Constant 0.1 uM 1 uM
k1O 1817 ± 10% 3017 ± 9.6%
kO1 87 ± 5.4% 188 ± 5.6%
k12 1086 ± 10% 1062 ± 11%
k21 47 ± 24% 129 ± 65%
k23 49 ± 36% 514 ± 43%
k32 8.8 ± 32% 23 ± 35%
k34 2 ± 36% 12 ± 38%
k43 0.84 ± 43% 1.9 ± 32%
k45 0.1 ± 99% 0.27 ± 46%
k54 0.14 ± 67% 0.185 ± 25%
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Table A.2.6: Rate constants for a star mechanism.
C
r -  k- r
Ku
^  k« /~
^  k,, \J  ^  ^
c c
Table A.2.6
Rate Constant 0.1 juM 1 uM
k1O 612 ± 41% 99 ± 42%
kO1 8.9 ± 37% 3.6 ± 18%
k2O 3.3 ± 24% 0.13 ± 11%
kO2 1 3 ± 14% 11 ± 14%
k3O 43 ± 29% 2.11 ± 44%
kO3 9.8 ± 17% 7.2 ± 16%
k4O 0.25 ± 18% 0.97 ± 99%
kO4 6.7 ± 20% 1e-4 ± 99%
k5O 3696 ± 14% 3553 ± 5.6%
kO5 53 ± 9.6% 62 ± 5.8%
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CHAPTER 3: Synchronization of High-Sensitivity a4p2 
Nicotinic Acetylcholine Receptors2 
Abstract
Understanding the mechanism of modulation of nAChRs by potential compounds such 
as desformylflustrabromine (dFBr) allows for greater insight into the potential uses and 
drawbacks of the drug on a synaptic level. We tested a variety of classical mechanisms 
to determine the best kinetic representation of our single-channel data. Our data for the 
human high sensitivity, (c42P23), nicotinic receptors was best explained using an 8-state 
MWC based gating model. It was found that dFBr increased the open probability via an 
increase in the opening frequency of the diliganded open state in dFBr (by increasing 
the opening rate of the diliganded receptor). Also, dFBr increased the mean open time 
of the mono-liganded open state. In order to determine the consequences of the effects 
of dFBr on signaling at cholinergic synapses, we simulated macroscopic responses to 
concentration jumps. At high simulated concentrations of ACh, potentiation was 
primarily exhibited through the increase in open frequency into the diliganded open 
state, while at low concentrations of ACh, potentiation primarily occurred through the 
increase in mean open time for the mono liganded open state. For 1 mM ACh 
simulated macroscopic responses, we found an increase in peak Popen in the presence 
of dFBr, increasing Popen from 0.4 to 0.6. The increase in peak Popen in the presence of 
dFBr is due to the synchronization of openings, however, dFBr reduces overall charge 
transfer at simulated concentrations above 1 uM ACh. The simulated responses 
demonstrated that the decrease in charge transfer is primarily due to an increase in 
probability of being in the desensitized state D2. The negative effect dFBr is having on
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the high sensitivity receptor could be due to the presence of the Good’s buffer HEPES 
in the recording solution. Future studies will need to consider the buffer’s potential 
effects when analyzing results.2
2 D em m erly , A ., Edm onds, B .W . 2016. S ynchron iza tion  o f  h ig h -se n s itiv ity  c 4 0 2  n ico tin ic  
acety lcho line  receptors. J. Gen. Physiol.
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3.1 Introduction
The current knowledge on the physiological role and activation of a402 nicotinic 
acetylcholine receptors (nAChRs) in the central nervous system (CNS) is limited. The 
heteromeric a402 AChRs are widely distributed throughout the brain and may be 
involved in nicotine addiction as well as a variety of neurological disorders, including 
Alzheimer’s disease and autism. The high-sensitivity (HS) a402 nAChR is the least 
studied of the two stoichiometric forms and very little is known about their synthesis and 
regulation (Changeux, 2010). Due to its potential role in several psychiatric and 
neurological disorders, HS a402 nAChRs are an important therapeutic target. (Nelson 
et al., 2003; Khiroug et al., 2004).
A novel strategy in treating a variety of cognitive diseases is to utilize compounds 
that enhance responses of nAChRs and potentially increase transmission at synapses 
where nAChRs are deficient, thus restoring functional properties. Allosteric modulators 
are a class of compounds that bind at a site distinct from the endogenous ligand 
acetylcholine, and therefore do not compete with the agonist, preserving the natural 
cholinergic signal. Desformylflustrabromine (dFBr) has been previously identified as a 
novel positive allosteric modulator (PAM) of a402 nAChRs with no apparent potentiation 
of other subtypes (Sala et al., 2005). Previous studies have suggested that the 
potentiation exhibited by dFBr is due to an alteration in channel gating kinetics, but the 
mechanism by which dFBr modulates the HS a402 receptor is currently unknown 
(Weltzin and Schulte, 2010; Sala et al., 2005; Kim et al., 2007).
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In this study we are taking a first step in determining how dFBr modulates by 
providing a comprehensive gating model for the high sensitivity receptors. Once it is 
known how these receptors are activated in the CNS, then our model will provide a 
framework for how dFBr will potentiate on a synaptic level. Obtaining a mechanism that 
can describe the effects of the positive allosteric modulator, dFBr, will allow greater 
insights into its uses and potential shortcomings in future studies.
3.2 Materials and Methods
3.2.1 Cell Techniques
HEK-293 cells were maintained in minimum essential Eagle medium (MEME) 
supplemented with 1% Glutamax (Gibco), 10 % bovine growth serum, antibiotic 
penicillin streptomycin (200 pg ml-1), 100 pg/mL G418 (Thermo-Fisher) and pH adjusted 
to 7.4. Cells were incubated at 37°C in a humidified atmosphere of 5% CO2, passaged 
weekly and plated onto 35mm tissue culture dishes (Becton Dickinson) one day prior to 
experiments. Human a4 and p2 neuronal nicotinic receptor subunits were stably 
transfected into HEK-293 cells and passaged weekly one day prior to experiments. The 
cells were provided to us by Dr. Henry Steinbach at Washington University, St. Louis, 
MO.
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3.2.2 Electrophysiology Techniques
All salts were obtained from Sigma Aldrich. To avoid receptor rundown all patch- 
clamp recordings were made in the cell-attached configuration at room temperature. 
Membrane potential was zeroed with a K+-based extracellular solution containing (in 
mM): 142 KCl, 5.4 NaCl, 2 CaCl2, 1.7 MgCl2, 5 HEPES, 10 glucose and pH adjusted to 
7.4. Pipette solution contained (in mM): 5.4 KCl, 142 NaCl, 2 CaCl2, 1.7 MgCl2, and 5 
HEPES pH adjusted to 7.4. Agonist and PAM solutions were made on the day of the 
experiment.
Experiments were performed using a Nikon Eclipse FN1 microscope. Pipettes 
were pulled to a resistance of 10-14 MO using a PMP-102 Micropipette puller (Microdata 
Instrument Inc.) and thick-walled borosilicate capillary glass tubing with flame polished 
ends (Warner Instruments). In order to enhance signal to noise ratio pipette tips were 
coated with Sylgard (Dow Corning 184). Prior to recording the pipettes were front and 
back filled with the pipette solution containing the appropriate concentration of ACh (0.1 
-10 pM) with or without dFBr (1 pM). Patches were voltage-clamped at -80 mV with a 
HEKA EPC-10 Elektronik amplifier using PATCHMASTER software. Data were low-pass 
filtered (4-pole Bessel, -3dB) at 10 kHz and digitized to the computer at 100 kHz. 3.2.3
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3.2.3 Definition of Bursts and Clusters
Bursts were defined as in section 2.2.4 and by a critical value (tcrit) using the 
equation:
Am pr* e-Tcrit/Taul=Amp2* (1 -  e- Tcnt/Tau2)
Tcrit is the cutoff duration between exponential components and equalizes the area 
under the overlapping tails of the distributions. Where Amp1 and Amp2 are the weights of 
the first and second components respectively for bursts or second and third components 
for clusters. Tau1 and tau2 are the time constants computed from MIL. Each tau in the 
distribution contributes one exponential component to the probability density function 
(thick line in distributions). Bursts and clusters that held doubles were discarded from the 
analysis.
3.2.4 Model Fitting and Simulations
Idealized records of single-channel events were constructed and dwell time 
distributions fitted with models in QuB as previously described. Rate constants were 
obtained using an algorithm (MIL described) (Qin, 2004; Qin et al., 1997, 1996). All 
simulations performed utilized scheme 2 for control (1 uM ACh) and modulated (1uM 
ACh + 1 uM dFBr). Responses were made using rate constants from a group fit that 
contained greater than n=3 for all conditions, except 10 uM data. The open and closed 
distribution used in figures was based on patches that contained the most events
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(openings + closings). In order to distinguish between models, we relied on various 
factors including, the fit of the probability density function to the data, the degree of 
agreement in activation steps between 0.1 and 1.0 uM ACh, as well as simulated peak 
Popen and EC50 values. Log likelihood was not used as a best fit parameter due to its 
inability to distinguish between models containing a similar number of states (Elenes 
and Auerbach, 2002). Monte Carlo simulations of macroscopic currents in Figure 3.4A 
were made in QuB Express for 10,000 channels with a unitary amplitude of 1 pA and 
standard deviation (SD) of Gaussian noise of 0.15 pA (Nicolai and Sachs, 2013). 
Current values were converted to and displayed as open probabilities (Popen) in Igor Pro 
(WaveMetrics). Stability plots were generated using QuB’s stability function with a 
window size (events) of 15 and an overlap (events) of 2.
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3.3 Results
3.3.1 Conductance of HS Receptors in the Presence of dFBr
Allosteric modulators can exhibit potentiation a variety of ways, including 
increasing an ion channels conductance. To determine whether dFBr increases chord 
conductance as a means of potentiating the receptor channel openings with one 
primary amplitude were analyzed from cell-attached recordings obtained using low 
concentrations of ACh (0.1 and 1.0 uM ACh). Similar to previous reports we found that 
c4p2 receptors demonstrated a high sensitivity component to ACh, having a 
conductance of ~20 pS (Buisson and Bertrand, 2001). Figure 3.1 shows open point 
amplitude histograms for HS receptors in 1 uM ACh and 1 uM ACh + 1 uM dFBr. Fitted 
open point amplitude histograms yielded a chord conductance of 19.5±1.8 pS 
(mean±SD; n=5) and 19.9±0.34 pS (n=4) in the absence and presence of dFBr 
respectively. The presence of dFBr had no significant effect on the HS conductance 
levels. Traces (1 s) reveal that dFBr does not significantly alter the mean open time 
(the mean duration of a single opening). This suggests that when dFBr is applied the 
average open state lifetime of the receptor is not affected by the drug. Inward 
rectification of c4p2 has been observed in previous reports (Buisson et al., 1996) and 
our recordings did not exhibit HS openings above 0 mV. I/V data was collected for 1 uM 
ACh (n=3) and 1 uM ACh + 1 uM dFBr (n=4) between -80 mV and -30 mV and was 
fitted with a linear equation. The fit yielded slope conductances of 19.9 for ACh and
19.8 for ACh + dFBr. The I/V relationships demonstrate that dFBr does not increase the 
chord conductance as a means of potentiation. The control values are very close to the
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previously reported conductance values of ~20 pS (Buisson et al., 1996). Long 
contiguous sweeps (50 s) do not show the obvious effect of dFBr on HS receptor gating.
3.3.2 Gating o f HS Receptors in ACh and ACh + dFBr
Recordings of HS a402 in 0.1 (n=4), 1 (n=4), 10 (n=2) uM ACh or 1 uM ACh + 1 
uM dFBr (n=3) yielded multiple patches for all conditions that contained enough 
openings for analysis. The average number of openings for all ACh patches were 
917±395, with a range from 295 to 1250 openings. The average number of openings 
for 1 uM ACh + 1 uM dFBr were 1698 openings. Incidents of double openings were 
observed in 1 out of 3 of the 0.1 or 1 uM ACh patches, but all other conditions showed 
evidence for more than one channel. The probability of a channel being open for the 
HS subtype is very low (~ 0.001 to 0.005). These values are taken from the most stable 
0.1 and 1.0 uM ACh patches, which contained two observable channels. Figure 3.2 
shows 50s segments for 1 uM ACh and 1 uM ACh + 1 uM dFBr. These two data sets 
show HS receptor gating for ACh with and without dFBr. Visually an effect is not 
immediately apparent.
Single-channel recordings often contain several channel openings in succession
followed by long periods of closings. Our HS data contained none of these classical
bursts, and most ‘bursts’ in our data contained only one opening. Figure 3.3 shows the
burst length and apparent open lifetime of the bursts for 0.1-10 uM ACh and 1 uM ACh
+ 1 uM dFBr. Two exponentials were needed to fit the distribution of the burst length
and also to fit the total open time per burst. Both of these were very similar since the
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majority of bursts consisted of one apparent opening. As the concentration increased, 
the slower component (time constant is) becomes shorter. The presence of dFBr 
increased the apparent open lifetime, increasing time constants if  from 2.9 to 4.5 ms 
and is from 3.7 and 10.7 ms. There is a similar effect seen on the burst length 
increasing constants if  from 3.12 to 4.5 ms and is from 3.4 and 5.04 ms. Our calculated 
burst parameters were in agreement for dFBr (estimated burst open lifetime 4.7 ms) 
with the time constants obtained from the fits, whereas our ACh calculated burst 
parameters were larger than our fitted time constants (estimated burst open lifetime
12.9 ms). A possible explanation for this discrepancy is an underestimation in one of 
the desensitized states by the model. Clusters were defined by a tcrit in between 2nd and 
3rd components (see methods). Cluster length (Figure 3.4 A) and apparent open 
lifetime (Figure 3.4 B) required two exponentials to fit. For burst length if  showed no 
significant difference between 0.1 to 10 uM ACh, whereas is decreased from 4.01 ms to 
1.83 ms for 0.1 to 10 uM ACh. The slow and fast time constants for the cluster open 
lifetimes decreased as concentration increased from 0.78 to 0.33 ms for if  and 2.1 to
1.6 ms for is for 0.1 to 10 uM ACh. Clusters were dominated primarily by single 
openings and lower concentrations having more openings (3.4 C).
It is a common problem in the single-channel analysis of low Popen receptors to 
have a level of uncertainty in the number of channels within the data. Therefore, it is 
beneficial to determine if instability exists in the data and how that will affect kinetic 
analysis. Stability plots for ACh concentrations of 0.1 uM to 10 uM ACh and 1 uM ACh 
+ 1 uM dFBr were generated using QuB’s stability function and segments contained 15
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events (Figure 3.5, see methods). These plots originated from the same patches used 
in model analysis, as well as burst and cluster distributions. Both 0.1 and 1 uM ACh 
data sets contained more than one observable channel and were stable with a Popen of 
0.0067 and 0.016 respectively. The 0.1 and 1 uM ACh patches were the only 
completely stable patches despite showing more than one observable channel. Other 
0.1 and 1 uM ACh patches had similar low occupancy (<0.01), and contained only one 
observable channel, but had decreased activity after ~800 segments. The 10 uM ACh 
patches activity decreased after ~500 segments. The 1 uM ACh + 1 uM dFBr patches 
were not stable near the end of the recordings and activity decreased after ~1000-1200 
segments. The observed occupancy for the 10 uM ACh (0.0011) data was lower when 
compared to the 0.1 and 1 uM patches, even though more than one channel was 
observed in the 10 uM data. All 1 uM ACh + 1 uM dFBr patches showed some amount 
of instability (Popen= 0.05, Figure 3.5). This instability is likely caused by channels 
dropping out as the patch progresses or receptors entering an extremely long lived 
desensitized state that is concealed by more than one channel being present in the 
patch. Instability due to channels dropping is the most likely culprit with all of the dFBr 
data, but this is less likely for the 10 uM data, which begins with very low occupancy 
and contain more than one observable channel.
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3.3.3 Fitting Mechanisms to Single-Channel Data
The mechanism of modulation exhibited by dFBr was investigated by fitting a 
variety of mechanisms to single-channel data. Mechanisms that contained activation 
steps were fitted independently to each single-channel concentration group which 
included 0.1, 1.0 and 10 uM ACh and 1 uM ACh + 1 uM dFBr. A concentration group 
was defined as all patches of the same concentration, (e.g. all 1 uM), fitted 
simultaneously as a group. The records were kept intact and were not divided up due 
to bursts and clusters primarily consisting of single openings (see methods). We tested 
4 different types of activation mechanisms, Katz and Thesleff based model, Monod- 
Wyman-Changeux (MWC) based model, and MWC mechanisms that contained two or 
three desensitized states. In our MWC models we omitted the unliganded open state 
due to the low probability of these openings occurring in naive HS nAChRs. All models 
utilized activation rate constant constraints of 2 k+1 and k+1 for the binding rates, and 2 k-1 
and k-1 for the unbinding rates, which assumes that both sites on the receptor are 
available for agonist binding. Mechanisms were also constrained with the requirements 
of microscopic reversibility.
Classical mechanisms such as the Katz and Thesleff and the MWC have been 
previously utilized to describe the gating kinetics of ACh receptors. We first tested the 
Katz and Thesleff based mechanism (See Figure 3.6) and found that 10 uM errors were 
extremely high (>100%) and most of the rates were vastly different from the other 
patches (See Table 1). Activation rates between 0.1 and 1 uM ACh changed 5-fold, 
while the activation rates for the 10uM data were 1000x smaller than for the other two
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concentrations. The overall fits of the probability density function to the data was 
decent, with 10 uM ACh data fitting the worst (Figure 3.7). Deactivation rates in the 
Katz and Thesleff model for the dFBr data are much lower when compared to controls, 
while 02 is 10x lower than control. When simulated, the Katz and Thesleff configuration 
gave extremely high Popen (~0.85) values and the presence of dFBr displayed inhibition.
The MWC mechanism has been widely used to describe many ion channels.
This mechanism postulates that there are two conformational states a channel can take 
on, open and closed, each with different affinities for ligand. For the MWC we imposed 
constraints so that the activation rate constants are equivalent for each ligand bound.
For this model type we have two molecules of agonist binding, with one cycle, and 6 
free parameters. Of the two classical mechanisms the MWC model gave consistent 
activation rates between the 0.1 and 1 uM ACh data. Examples of open and shut time 
distributions are shown in Figure 3.8. Since the MWC scheme lacks desensitized states 
the fits were poor and thus we decided to use the MWC as a base model. One to three 
desensitized states were added to the basic model and their positions tested. Positions 
included a D state distal to an O state or to the diliganded closed state.
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3.3.4 Modified MWC Schemes
It was difficult to find a desensitization configuration that would result in a slow 
desensitization time course as observed in previous reports (Weltzin et al., 2014). We 
first tested multiple two-desensitized state configurations, and scheme 1 is an example 
of one such configuration (Figure 3.6). This particular configuration gave the lowest 
errors, unlike configurations that had desensitized states distal to O1 and O2 or C3 and 
O2. With only two desensitized states, placing one distal to O1 and O2 resulted in no 
observable desensitization in simulated macroscopic responses. While having the 
desensitized states distal to C3 and O2 resulted in large error values and the lifetime of 
C3 being much lower than our imposed dead time (Figure A.3.1 and Table A.3.1). 
Closed and open time distributions are shown for scheme 1 in Figure 3.9 and rate 
constants in Table 3.3. Multiple configurations that contained three desensitized states 
were also tested. Schemes included all three desensitized states off O2 as well as a 
desensitized state off of O1 and two off of O2. Both configurations resulted in large 
errors for all conditions and poor fits to the closed time distributions. All three 
desensitized states being adjacent to O1, O2 and C3 was also tested, but the errors 
and fits gave us less confidence in the mechanism compared to scheme 2 (Figure 3.10 
and Table 3.4).
All of the MWC based models that were tested gave a consistent high Popen 
(>0.6) for 0.1 uM ACh data. The current cause for this is most likely due to larger rate 
constants between O1 and O2, as lowering those rates in simulations to values seen in 
the 1 uM ACh model resulted in a lower simulated Popen values, which were comparable 
to the 1 uM data (~0.3- 0.4).
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3.3.5 Desensitization Based Mechanisms
We also investigated the possibility that our data lacks activation information due 
to the closed time distributions only displaying closings affiliated with entry into long 
lived closed states. When agonist concentrations are high, then almost all current can 
be attributed to the activation of diliganded AChRs (Elenes and Auerbach, 2002). High 
ACh concentrations can therefore lead to diliganded closed states being too brief to be 
detected. Mechanisms that only contained desensitized states as closed states were 
investigated and group fitted to data at different ACh (0.1, 1 and 10 uM ACh) and ACh + 
dFBr concentrations (1 uM ACh + 1 uM dFBr). Mechanisms are based off of QuB’s 
model search function and were the most common outcomes.
All desensitization models contain only one open state, which results in the 
probability density function not fitting the open duration distributions. Most group fits of 
the desensitization based models do not fit 10 uM data as well as the 0.1 or 1 uM ACh 
data. Scheme 5 (star) (Figure A.3.4) had the best overall visual fits compared to the 
other desensitization schemes. Whereas, scheme 6 (linear, Figure A.3.5) and scheme 
7 (Figure A.3.6) had the worst fits. The 10 uM data fits were poor for all desensitization 
schemes. In some of the schemes the lifetimes of all of the desensitized states 
increased with dFBr, including scheme 4 and scheme 7, with scheme 7 fits being 
equivalent to scheme 6. For all of the schemes it was noted that dFBr reduced the 
likelihood of entry into the majority (4/5 or 3/4) of the desensitized states within the 
models. Also, there were cases in all of the desensitized models where dFBr increased 
the lifetime of some of the desensitized states. Of all of the desensitization schemes
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the most probable would be Scheme 5 (star) due to the probability density function 
fitting the best out of all three and lowest overall errors modulated and unmodulated.
3.3.6 Simulation of Macroscopic Currents
Conducting simulations of macroscopic responses with fitted models is a 
powerful tool in determining if the estimated kinetic parameters support potentiation. 
Scheme 2 was utilized to investigate dFBr’s potentiation over a range of ACh 
concentrations by simulating macroscopic responses to concentration jumps (Figure 
3.11A). Potentiation of peak currents occurred at all concentrations with the largest 
percentile increase occurring at low concentrations (<5 uM), and an increase in peak 
current maintained at larger concentrations (> 50 uM) (Figure 3.11 B). Fitted Hill 
equations to peak responses yielded (mean ±SD) EC50 values and Hill slopes of 
23.5±1.3 uM and 1.1±0.05 for ACh, and 18.1±0.68 uM and 0.91±0.03 for dFBr. Peak 
open probability for 1 mM concentration jumps of ACh was ~0.42, dFBr increased peak 
open probability to ~0.63. The concentration dependence of changes induced by dFBr 
for macroscopic responses is shown for 1 uM-1 mM ACh (Figure 3.11 C). The decay of 
responses at all concentrations were best fit with two exponentials. At concentrations of 
1 mM, ACh gave a fast time component of ~17 ms (if) and a slow time component (is) 
of ~790 ms. The presence of dFBr significantly reduces these time components, 
bringing if  down to 5 ms and is down to 6 ms.
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We simulated low concentrations of ACh using scheme 2 for ACh and ACh + 
dFBr in order to determine if dFBr affected low concentrations of agonist the same as 
high concentrations. Figure 3.12 A shows the effect of dFBr at low concentrations of 
ACh (1, 3 and 5 uM). At concentrations greater than 3 uM, dFBr gives increased 
desensitization, whereas at concentrations lower than 1 uM, dFBr increased 
potentiation without increasing desensitization. We were interested to determine if 
charge transfer changed significantly in the presence of dFBr, and if that change is 
correlated to agonist concentration. At ACh concentrations of 1 mM dFBr decreases 
charge transfer 5.2-fold down to 1.8-fold at 5 uM. Charge transfer did not increase in 
the presence of dFBr until concentrations were <1 uM. We were interested to find out if 
dFBr has a greater impact on the fast (if) or slow (is) time component. While dFBr does 
decrease if  for the HS receptors, it was found that is was more affected by dFBr. For 
the ACh model, if  maintains a steady level at ~100 uM reaching ~17 ms, while in dFBr 
this occurs at lower concentrations (<10 uM) (Figure 3.12 B). dFBr sees a significant 
reduction in the slow time course of decay, reducing is to one tenth its ACh value at 
concentrations greater than 50 uM (Figure 3.12 C).
When individual rate constants were changed during macroscopic simulations it 
was found that potentiation was different based upon the concentration of ACh used for 
stimulus. At high (1 mM) simulated ACh concentrations the primary mode of potentiation 
exhibited by dFBr is an increased rate of entry into the diliganded open state O2. This 
potentiation is offset by an increase into the desensitized state D2, accounting for the 
observed increase in desensitization as the simulated concentration of ACh increases
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(Figure 3.11A). At low concentrations (<10 uM) potentiation primarily occurs by an 
increase in the mean open lifetime of O1. dFBr increases the open probability, 
synchronizing openings in simulated macroscopic currents, giving potentiation at the 
peak.
3.3.7 Occupancy Probabilities and Agonist Concentration
The aim of examining occupancy probabilities was to determine how dFBr 
increased macroscopic desensitization, and if potentiation was equivalent at all 
concentrations. Figure 3.13 shows the occupancy probabilities for concentration jumps 
into 10 uM, 100 uM, and 1 mM ACh. At high concentrations (1mM) the open probability 
is approximated by Po2 for ACh and ACh + dFBr models, because Po1 is <0.005, as the 
simulated concentration decreases, PO1_ACh increases to 0.032. At high concentrations, 
dFBr increased the peak response 1.6-fold (PO2_ACh = 0.38, PO2_dFBr = 0.601). For jumps 
into low concentration of ACh (10 uM) dFBr increased open probability by a factor of 2.3 
(PO2_ACh + PO1_ACh = 0.1, PO2_dFBr + PO1_dFBr = 0.23).
For concentrations greater than 100 uM an increase in Po2 was the primary 
contributor to potentiation, whereas below 100 uM Po1 becomes a significant 
contributor. For all concentrations PD2 and PD3 both contributed to desensitization with 
Pd3 contributing the most in ACh, whereas Pd2 contributed the most in dFBr. In all case 
Pd1 contributed very little to desensitization. For concentrations greater than 100 uM 
PD2_dFBR was larger than Pd2_aci- i, and is the primary cause for increased desensitization 
seen by dFBr in macroscopic simulations. PD3_dFBR is < 0.1 compared to PD3_ACh being
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>0.65 at 0.500 ms. The lower probability of entering D3 leads to more entries into O2 
contributing to initial potentiation.
3.3.8 Potentiation During a Pulse of High Agonist Concentration
We examined the macroscopic responses to an agonist concentration profile 
typical of fast synapses by driving models with an alpha function with an agonist 
concentration of 1mM. Peak open probability in ACh (Po2_ACh = 0.35) was slightly lower 
compared to concentration jumps (Po2_ACh = 0.38) of the same concentration. Popen was 
larger for dFBr when a similar comparison was made (Po2_dFBr = 0.634) when driven 
with an alpha function versus (Po2_dFBr = 0.601) when driven with a concentration jump. 
Overall, dFBr yielded a 1.8-fold increase in peak amplitude.
The development of desensitization following a pulse of agonist was faster with 
dFBr, while recovery from desensitization was significantly slower. The presence of 
dFBr decreased the time to peak of Pd2 (PD2_ACh = 41.2 ms, PD2_dFBr = 27 ms) and Pd3 
(PD3_ACh = 8.1 ms, PD3_dFBr = 5.3 ms). PD2_dFBr was lower with the alpha function versus 
the concentration jump, while Pd3 maintained similar levels, despite having a longer 
decay time course in the presence of dFBr (PD3_ACh i=6.7 s, PD3_dFBr i=21.8 s).
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3.4 Discussion
3.4.1 Fitted Models
We attempted to fit HS a402 nAChR single channel data with 3 model types and 
their variants. The desensitization model types were just a subset of possible 
configurations that would be viable for describing the desensitization time course of the 
receptors. The classical mechanisms such as Katz and Thesleff and MWC have been 
successfully utilized in prior studies to describe nicotinic receptors (Edelstein et al.,
1996; Colquhoun and Sakmann, 1985). In their simpler forms the primary classical 
mechanisms of Katz and Thesleff and MWC failed to describe the single-channel data 
that they were fitted to, even when the Katz and Thesleff contained a modification of an 
additional open state. Modifying the MWC to account for desensitization proved to the 
most successful. We found that a model containing 3 desensitized states gave the best 
overall fits, error values, and simulated currents. Some combinations gave simulated 
currents that demonstrated extremely long (>20s) desensitization time courses similar to 
or longer than those seen in previous whole cell experiments on oocytes, but these 
models contained the largest amount of error (Weltzin and Schulte, 2015). In our data 
we could not justify adding more than 3 desensitized states in an activation mechanism 
due to the lack of complexity in the closed time distribution and the possibility of more 
than one channel in our data. The likelihood that we are not capturing any activation 
information in our patches was also investigated This scenario is plausible given that 1 
uM ACh is around the EC50 for these receptors and previous reports on nicotinic 
receptors have observed a lack of activation data at high concentrations (Elenes and 
Auerbach, 2002).
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Several desensitization schemes were explored for all concentrations, but an 
additional open state was found to be needed to describe the open lifetime distribution. 
While the closed time distributions appear rather simple, they most likely contain several 
desensitized states that are difficult to resolve. This added with the instability at the end 
of the dFBr data adds additional complexity to result interpretation.
3.4.2 Scheme 2 Predictions
The MWC based mechanisms gave consistent activation rates across the two 
concentrations of 0.1 and 1 uM ACh. The MWC modified scheme 2 gave the most 
promising results in terms of errors, peak open probability and desensitization. We 
discounted any schemes that when simulated over long periods (>25s) gave high 
steady state currents and no visible desensitization. In order to test the effects dFBr 
would have on macroscopic currents we used models obtained from 1 uM ACh and the 
1 uM ACh + 1 uM dFBr data. The primary finding was that dFBr potentiates peak 
currents of HS receptors across all concentrations. At higher concentrations (>5 uM) 
potentiation is offset by an increase in desensitization, resulting in overall lower charge 
transfer, while at very low concentrations (< 3 uM) dFBr increases the desensitization 
time course, and charge transfer increases. Potentiation at high concentrations is 
brought about via an increase in the amount of diliganded openings, while increased 
desensitization occurs via an increase into the desensitized state D2. This increase 
directly affects the slow desensitization time course, while having little effect on the fast 
time component. At low concentrations, potentiation primarily occurs via an increase in
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the mean open time of O1, as well as a decreased rate of entry into the desensitized 
state off of the diliganded closed state. While the concentration is not high enough for 
the change in desensitization to override potentiation, we do observe that receptors will 
be ‘pushed’ into the long lived desensitized states by the increased rate into the 
diliganded open state.
The potential implications our findings have for signaling will largely depend on 
where HS receptors are expressed and in how they are exposed to agonist. For 
signaling at classical fast synapses, dFBr could have significant consequences based 
upon the agonist concentration profile HS receptors are exposed to. At synapses where 
there are brief, high concentrations of ACh, dFBr will initially potentiate receptors before 
pushing them into desensitization. Based on our simulations this would result in an 
overall decrease in charge transfer. However, if the receptors are exposed to long 
lasting ambient (low) levels of ACh concentration, such as in a ‘volume transmission’ 
model (Ren et al., 2011; Descarries et al., 1997), then dFBr is capable of boosting 
receptor responsiveness and increasing overall charge transfer for HS receptors.
3.4.3 Model Discrepancies
All of our dFBr data contained instability that arose near the end of the patch.
This instability is due to either multiple receptors dropping out as the patch ages or dFBr 
having a greater effect on the open channel duration which becomes weaker as the 
patch progresses. The instability could also be a product of both scenarios. Loss of 
receptors is the more likely culprit as more than one observable channel is seen in the
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first half of the records. The 0.1 and 1 uM ACh data is very stable, and we have very 
high confidence in the results for those patches. Of all of our data for the 10 uM ACh 
patches consistently had only one observable channel, but were unstable near the end 
of the records and the initial Popen obtained from stability plots is very low. It was noted 
that at 10 uM the open time distributions became shorter, and it is possible that block is 
involved even at concentrations this low. Another consistent discrepancy was in the 10 
uM data all gave significantly lower activation rates compared to other concentrations. 
Whether this is due to open channel block on the single-channel level or another 
mechanism is currently unknown. Properties of potential block will have to be 
investigated further on a single-channel level with higher concentrations of agonist (25­
100 uM ACh).
There were consistent discrepancies throughout all of the MWC models. The 
most notable of these was that the 0.1 uM ACh data gave higher Popen simulated 
currents compared to the 1 uM ACh. This larger Popen is due to the fact that the 0.1 uM 
data has a 20-fold larger rate of entry into the diliganded open state. In our 1 uM data 
we do begin to see short closings disappearing which would account for the 
discrepancy between the two concentrations. All of the 0.1 uM models had higher rates 
between the singly-liganded and diliganded open state, which did not appear to have a 
large effect on simulated currents. We were unable to determine the reason behind the 
0.1 uM data having an increase in these rates. In future studies we will need to 
investigate lower concentrations of ACh (1 -50 nM) with dFBr and see if we still see 
similar effects as we have observed with 1 uM data.
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3.4.4 HEPES Effects on HS Single-Channel Data
In previous studies, HEPES appeared to be a PAM selective for the HS subtype 
compared to LS a402 and a7 nicotinic acetylcholine receptors (Weltzin et al., 2014). 
HEPES is thought to potentiate and inhibit by binding to the P2+/02- interface of the HS 
a4p2 receptors. It was also found that, inhibition of HEPES potentiated responses 
occurs at concentrations greater than 100 mM HEPES. Due to the binding location of 
HEPES, the presence of the Good’s buffer could be altering our HS dFBr data.
In oocyte preparations, the presence of a HEPES buffer altered the efficacy of 
dFBr for the HS a4p2 receptors. The lower efficacy of dFBr in the HS subtype may be 
the result of competition between HEPES and dFBr (Weltzin et al., 2014). In our 
preparations we utilized 5 mM of HEPES buffer, as is common in a lot of 
electrophysiology recordings. We believe that the presence of HEPES on HS receptors 
gives the appearance of increased desensitization in dFBr. This is due to HEPES 
binding at the p2+/p2- interface, offsetting dFBr’s steady state potentiating effects by 
inhibiting the receptor. Therefore, it would be wise in future single molecule studies of 
HS a4p2 receptors to not utilize HEPES as a buffer in order to eliminate any 
unnecessary alterations in the observed gating.
Overall, we have provided a larger picture of the kinetics on a single-channel 
level of the high sensitivity a4p2 nAChR and give more insight into the potential effects 
of dFBr on these receptors. Our data supports dFBr exhibiting potentiation by 
increasing peak current at all concentrations, but an overall decrease in charge transfer 
is observed at higher concentrations potentially due to the presence of HEPES. The
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effect this has on desensitization largely depends on the concentration profile of ACh, 
with increased desensitization existing at higher concentrations. Our model offers one 
possibility to what we observed on a single-channel level for the HS receptors, and 
provides a starting point for future analysis of dFBr analogues.
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Figure 3.1: Unitary conductance’s of a42023 receptors. (A) Open point amplitude 
distribution for high sensitivity (HS) conductance channels in the absence [19.5 pS ± 1.8 
(mean±SD), black traces] and presence [19.9 pS ±0.34 (mean ±SD), blue traces] of 
dFBr with respective traces underneath. Calibration: 200 ms and 1.5 pA. (B) I-V plot 
shows mean value (± SD) for HS [19.9 ± 1.1 pS; n=7; black circles] recorded in 1 ^M 
ACh and HS receptors recorded in 1 uM ACh + 1 uM dFBr [19.8 ± 0.34 pS; n=4; blue 
squares]. I/V data gave slopes of ~20 pS in the absence and presence of dFBr with 
reversal potentials of 6.3 and 1.2 mV respectively.
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Figure 3.2: Steady state recordings of a42023 receptors. Steady state recordings of HS 
in 1 uM (top) and 1 uM ACh + 1 uM dFBr. Contiguous recordings of 50 s of data filtered 
at 1kHz (-3dB, 4-pole Bessel). Calibration: 100ms, 1.5 pA.
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Figure 3.3: Burst characteristics of a42^ 23 receptors. Distributions of burst length (left) 
and open lifetime (right). Distributions are fitted with two exponentials (red line) and are 
plotted up to 20 ms for comparison. Varied concentrations (0.1 ^M, 1 ^M, and 10 ^M) 
of ACh are compared [tcrit: 1.13 ms, 1.65 ms, and 2.8 ms respectively] to 1 ^M ACh + 1 
^ M dFBr (tcrit: 0.57 ms). Bursts usually contained single opening at concentrations 
greater than 0.1 ^M and are defined in methods. Bursts length time constants slightly 
diminishes with increasing concentration [0.1 ^M: 11 = 1.2 ms, 12= 5.9 ms; 1 ^M: 11 = 3.12 
ms, T2= 3.4 ms; 10 ^M: 11 = 0.96 ms, 12= 1.23 ms] with the presence of dFBr increasing 
is [i 1 = 4.5 ms and 12= 5.04 ms]. A similar effect is observed with open lifetime [0.1 ^M: 
T1= 1.1 ms, i 2= 5.8 ms; 1 ^M: 11 = 2.9 ms, 12= 3.7 ms; 10 ^M: 11 = 0.9 ms, 12= 1.3 ms] 
with dFBr also increasing apparent open lifetime [i1=4.5 ms and 12= 10.7 ms].
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Figure 3.4 Cluster characteristics of a42023 receptors. See caption on next page
Figure 3.4: Cluster characteristics of a42023 receptors. Distributions of cluster length 
(left), open lifetime (middle), and openings per cluster (right). Distributions are fitted with 
two exponentials (red line) for 0.1 uM (tcrit: 31.5 ms), 1 uM (tcrit: 42.2 ms) and 10 uM ACh 
(tcrit: 20.4 ms) and 1 uM ACh + 1 uM dFBr (tcrit: 5.33 ms). The determination of critical 
time is described in methods. (A) Cluster length for 0.1-10 uM ACh and 1 uM ACh + 1 
uM dFBr. Distributions are plotted up to 80 ms for comparison between them. Cluster 
length decreases with increasing ACh concentrations (0.1 ^M: i 1= 0.297 ms, i 2= 4.01 
ms; 1 uM: i 1= 0.49 ms, i 2= 2.43 ms; 10 uM: i 1= 0.37 ms, i 2= 1.83 ms). The presence 
of dFBr increased the long time constant for cluster length (i 1= 1.89 ms, i 2= 8.48 ms). 
(B) Distribution of open lifetime for 0.1 to 10 uM ACh and 1 uM ACh + 1 uM dFBr. 
Distributions are plotted up to 40 ms for comparison. Open lifetimes decrease with 
increasing concentration [0.1 uM: i 1= 0.78 ms, i 2= 2.1 ms; 1 uM: i 1= 0.41 ms, i 2= 1.9 
ms; 10 uM: i 1= 0.33 ms, i 2= 1.6 ms]. (C) Histograms for openings per burst for 0.1-10 
uM ACh and 1 uM ACh + 1 uM dFBr
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Figure 3.5: Stability plots for a42023 receptors. See caption on next page.
Figure 3.5: Stability plots for a42023 receptors. Segments were plotted vs occupancy of 
the open state for 0.1-10 ^M ACh and 1 ^M ACh + 1 ^M dFBr. 0.1 ^M [top-left; 
0.0067±0.014 (mean±SD)] and 1 ^M ACh [top-right; 0.016±0.022 (mean±SD)], both 
contained one observable channel and were the most stable. 10 ^M [bottom-left; 
0.0011±0.0009 (mean±SD)] loses activity after ~500 segments and 1 ^M ACh + 1 ^M 
dFBr [bottom-right; 0.0502±0.04 (mean±SD)] loses activity after ~1200 segments, both 
contained more than one observable channel.
Figure 3.6: a42023 receptor mechanisms. Mechanisms fitted to 0.1-10 ^M ACh and 1 
^M ACh + 1 ^M dFBr data. Scheme 1-3 are mechanisms that include activation 
including classical Katz and Theslaff mechanisms. Scheme 3-7 are desensitization 
models based upon most common outcomes for QuB’s model search.
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Figure 3.7: Katz and Thesleff model fits. Fits for the modified Katz and Thesleff shown 
in Figure 3.6 for ACh concentrations 0.1 -10 ^M and 1 ^M ACh + 1 ^M dFBr (bottom).
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Figure 3.8: MWC model fits. Fits for the MWC shown in Figure 3.6 for ACh 
concentrations 0.1 -10 uM and 1 uM ACh + 1 uM dFBr (bottom).
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Figure 3.9: Scheme 1 model fits. Open and closed duration distributions from patches 
for 0.1 uM, 1 uM ACh and 1 uM ACh 1 uM dFBr (top, middle and bottom respectively) 
fitted with gating model scheme 1 shown in Figure 3.6. Scheme 1 is a modified version 
of the MWC model in Figure 3.4.
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Figure 3.10: Scheme 2 model fits. Open and closed duration distributions from patches 
for 0.1 ^M and 1 ^M ACh (top, middle and bottom respectively) fitted with gating model 
scheme 2 shown in Figure 3.6. Scheme 2 is modified version of MWC models shown in 
Figure 3.4.
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Ar
Figure 3.11A: Concentration dependence of peak and steady-state currents for scheme 
2. (A) Simulated currents are shown for the ACh (black traces) and dFBr (blue traces) 
MWC based scheme 2 driven by 2.5 s jumps into 10 ^M (top), 100 ^M (middle), and 1 
mM (bottom) ACh. Exponential functions were fitted to the decay phase of currents for 
all concentrations. For 1 mM ACh the exponential functions were ACh scheme 2: A 1 = 
0.37, T1= 17 ms, A2=0.23, t2=794 ms, y0= 0.008. dFBr scheme 2: A1= 0.28, xf= 0.006 
ms, A2=0.32, xs=0.006 ms, y0= 0.05. Rise times (10 -  90%) for ACh and dFBr models 
with 1 mM ACh were 5.4 ms and 2.1 ms, respectively. Calibration bar: units of open 
probability (Popen).
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Figure 3.11B: Concentration dependence of peak and steady-state currents for scheme 
2. (B) Open probability (Popen) of peak (squares) and steady-state (stars) responses 
are plotted for ACh (black) and dFBr (blue) scheme 2 models as a function of ACh 
concentration (1, 5, 10, 50, 100, 200, 300, 500, and 1000 ^M). The Popen at the peak for 
saturating ACh concentration was ~ 0.42 for ACh and 0.63 for dFBr.
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Figure 3.11C: Concentration dependence of peak and steady-state currents for scheme 
2. (C) The ratio of dFBr to ACh scheme 2 Popen is shown as a function of ACh 
concentration. Potentiation of peak response (stars) was largest at very low ACh (600% 
increase for 1 ^M ACh) and declined to a steady value of 150% increase at 50 ^M ACh. 
Steady-state, desensitized responses (blue star) were diminished ~25% at 
concentrations above 1 ^M ACh.
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Figure 3.12A: Potentiation of peak and steady-state currents at low concentrations of 
ACh. (A) Simulated currents at low concentrations are shown for the ACh (black 
traces) and dFBr (blue traces) scheme 2 models driven by 15 s jumps into 1 ^M (top), 3 
^M (middle), and 5 ^M (bottom) ACh. Calibration bar: units of open probability (Popen).
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Figure 3.12B: Potentiation of peak and steady-state currents at low concentrations of 
ACh. (B) The fast time (if) component are plotted for ACh (black) and dFBr (blue) 
scheme 2 models as a function of ACh concentration (1, 3, 5, 10, 50, 100, 200, 300, 
500, 1000 ^M). dFBr only showed slower if  at 1 ^M ACh, higher concentrations yielded 
faster decay time courses.
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Figure 3.12C: Potentiation of peak and steady-state currents at low concentrations of 
ACh. (C) The slow time (is) component are plotted for ACh and dFBr scheme 2 models 
as a function of ACh concentration. Slower time component at concentrations higher 
than 10 ^M, almost completely disappears in the presence of dFBr.
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Figure 3.13: Occupancy probabilities of a42023 receptors using a concentration jump 
profile. Left: Occupancy probabilities (y-axis) of channel states after a concentration 
jump are shown for 10, 100 and 1000 ^M ACh (top to bottom) using either the scheme 2 
for ACh (solid lines) or scheme 2 for dFBr (dashed lines). Right: enlarged portion (grey 
squares, y-axis: 0.5 and x-axis: 0.15).
150
A
1.0
0.8
0.6
c<1)
Q .O
0.4
0.2 
0.0
0.00 0.02 0.04 0.06 0.08 0.10
Time (s)
Figure 3.14A: Response to a pulse of a high concentration of agonist. Occupancy 
probabilities are shown for models driven by an alpha function to mimic a synaptic 
agonist concentration profile. (A) Responses shown for the ACh model. Peak open 
probability (Po2) was 0.352 at 3.4 ms compared with 0.634 at 2.1 ms for dFBr (shown in 
B; 1.8-fold potentiation). The decay of P02 was fitted with one exponential (x=12.9 ms). 
Pd2 was fitted with two exponential components (A1=0.60, n =526 ms, A2=0.40, i2=633 
ms, y0=0), and Pd3 was fitted with one components (x=6.7 s, y0=0).
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Figure 3.14B: Response to a pulse of a high concentration of agonist. (B) For the 
dFBr model the decay of P02 was also fitted with one exponential component (x=5 ms). 
Pd2 was fitted with two components (A1=0.54, n =18.1 s, A2=0.46, i2=15.2 s, y0=0), and 
Pd3 was fitted with a single exponential (x=21.8 s, y0=0).
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Table 3.1: Rate constants for Katz and Thesleff mechanism
Table 3.1
R a t e
c o n s t a n t s
U n i t 0 . 1  ju M 1 u M 1 0  u M + d F B r
2k+1 M-1sc-1 7E9± 18% 1E9± 32% 2E6 ± 100% 5E9 ± 20%
k+1 M-1s1 -1 3.5E9 ± 18% 5.5E8 ± 32% 9.6E5 ± 100% 2.5E9 ± 20%
2k-1 4803 ± 16% 6720 ± 21% 2.5 ± 84% 1189 ± 17%
k-1 2401 ± 16% 3360 ± 21% 1.3 ± 79% 595 ±
P1 0.5 ± 11% 2.3 ± 6% 1.7 ± 8% 1.1 ± 6%
a1 657 ± 11% 447 ± 5% 1250 ± 6% 225 ± 4%
P2 2206 ± 36% 3113 ± 46% 2E-6 ± 100% 146 ± 66%
a2 619 ± 34% 156 ± 41% 0.001 ± 100% 164 ± 37%
2k+2 M-1s1 -1 2.2E5 ± 27% 6.5E5 ± 32% 1.2E6 ± 100% 8E5 ± 23%
k+2 M-1s1 -1 1.1E5 ± 18% 3.2E4 ± 31% 9.6E5 ± 100% 4E5 ±23%
2k-2 0.07 ± 29% 0.03 ± 33% 2.2 ± 32% 0.04 ± 30%
k-2 0.035 ± 29% 0.02 ± 40% 1.1 ± 31% 0.02 ± 30%
d+1 170± 33% 288 ± 51% 602 ± 100% 183± 30%
d-1 11 ± 17% 18 ± 36% 5.5 ± 100% 111 ± 32%
d+2 4.1 ± 65% 24 ± 26% 240 ± 100% 0.2 ± 100%
d-2 0.2 ± 50% 0.18 ± 28% 0.78 ± 100% 0.005 ± 100%
s
s
s
s
s
s
s
s
s
s
s
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Table 3.2: Rate constants for MWC mechanism.
c  ■ f e l
Table 3.2
Rate
constants
Unit 0.1 juM 1 uM 10 uM dFBr
2k+1 M-1s-1 4.9E7 ± 10% 2.4E7 ± 24% 4E4 ± 100% 4E5 ± 300%
k+1 M-1s-1 2.4E7 ± 10% 1.2E7 ± 24% 2E4 ± 100% 2E5± 300%
2k-1 s-1 1080 ± 16% 931 ± 20% 0.85 ± 21% 1.7 ± 12%
k-1 s-1 2167 ± 16% 466 ± 20% 0.42 ± 21% 0.85 ± 12%
P1 s-1 362 ± 24% 405 ± 24% 1.2 ± 100% 5.5 ± 100%
a1 s-1 818 ± 10% 28 ± 33% 1385± 100% 246 ± 100%
P2 s-1 15 ± 21% 303 ± 49% 1.4 ± 100% 4E-5 ± 100%
a1 s-1 0.1 ± 24% 85 ± 77% 329 ± 100% 6E-4 ± 100%
k+2 M-1s-1 2.2E9 ± 17% 580 ± 100% 92 ± 100% 3.8E7 ± 100%
k-2 s-1 103± 26% 0.001 ± 100% 0.001 ± 100% 103± 100%
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Table 3.3: Rate constants for scheme 1 fits.
Table 3.3
R a t e U n i t 0 . 1  u M 1 u M + d F B r
2k+1 M-1s1 -1 7.6E7 ± 98% 2.32E7 ± 26% 3.8E7 ± 100%
k+1 M-1s1 -1 3.8E7 ± 98% 1.16E7 ± 26% 1.9E7 ± 100%
2k-1 1712 ± 35% 2455 ± 12% 1472 ± 8%
k-1 856 ± 35% 1227 ± 12% 736 ± 8%
P1 396 ± 59% 114 ± 32% 137 ± 18%
a 1 287 ± 28% 671 ± 30% 175± 18%
P2 37 ± 22% 1543 ±59% 519 ± 100%
a2 0.1 ± 100% 29 ± 98% 22.4 ± 100%
k+2 M-1s 9.1E8 ± 100% 1.1E6 ± 100% 0.0048 ± 0.01%
k-2 147 ± 32% 0.76 ± 100% 1.3E-8 ± 100%
d+1 307 ± 60% 54 ± 11% 0.18 ± 53%
d-1 0.49 ± 70% 0.14 ± 11% 8.6E-4 ± 11%
d+2 33 ± 35% 99 ± 5% 99 ± 3.3%
d-2 361 ± 58% 5.3 ± 8% 0.7 ± 3.7%
s
s
s
s
s
s
1
s
s
s
s
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Table 3.4: Rate constants for scheme 2 fits.
Table 4.4
Rate Unit 0.1 uM 1 uM +dFBr
2k+1 M-1s-1 9 E7± 13% 2.8E7 ± 32% 3.5E7 ± 94%
k+1 M-1s-1 4.5E7 ± 13% 1.4E7 ± 33% 1.7E7 ± 94%
2k-1 s-1 794 ± 12% 1261 ± 20% 1678 ± 7.8%
k-1 s-1 397 ± 12% 631 ± 20% 839 ± 7.8%
P1 s-1 82 ± 52% 52 ± 42% 178 ± 95%
a1 s-1 1090 ± 8.5% 417 ± 35% 181 ± 90%
P2 s-1 6370b ± 18.6% 323 ± 71% 1000 ± 24%
a2 s-1 300± 17% 40 ±95% 27 ± 98%
k+2 M-1s-1 3.3E9 ± 25% 2E3 ± 99% 2.7 ± 74%
k-2 s-1 214 ± 18% 0.003 ± 99% 7.2E-6 ± 99%
d+1 s-1 3 ± 99% 2.7E-4 ± 99% 0.39 ± 56%
d-1 s-1 0.35 ± 98% 0.023 ± 99% 3.7E-5 ± 99%
d+2 s-1 57 ± 29% 44 ± 23% 195 ± 3.5%
d-2 s-1 0.33 ± 18% 4.3 ± 35% 0.77 ± 4%
d+3 s-1 975 ± 25% 236 ± 55% 63 ± 55%
d-3 s-1 43 ± 50% 0.19 ± 31% 0.08 ± 41%
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Appendix
Figure A.3.1: Model based off LS receptor mechanism. Open and closed duration
distributions from patches for 0.1 uM, 1 uM and 1 uM ACh + 1 uM dFBr (top, middle and
bottom respectively) group fitted with the LS gating model shown in Figure 2.6.
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Figure A.3.2: Scheme 3 model fits. Open and closed duration distributions from 
patches for 0.1 uM, 1 uM and 10 uM ACh (top, middle and bottom respectively) group 
fitted with gating model scheme 3 shown in Figure 3.6. Scheme 3 contains no 
activation steps.
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Figure A.3.3: Scheme 4 model fits. Open and closed duration distributions from
patches for 0.1 uM, 1 uM and 10 uM ACh (top, middle and bottom respectively) group
fitted with gating model scheme 4 shown in Figure 3.6.
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Figure A.3.4: Scheme 5 model fits. Open and closed duration distributions from
patches for 0.1 uM, 1 uM and 10 uM ACh (top, middle and bottom respectively) group
fitted with gating model scheme 5 (star) shown in Figure 3.6.
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Figure A.3.5: Scheme 6 model fits. Open and closed duration distributions from
patches for 0.1 uM, 1 uM and 10 uM ACh (top, middle and bottom respectively) group
fitted with gating model scheme 6 (linear) shown in Figure 3.6.
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Figure A.3.6: Scheme 7 model fits. Open and closed duration distributions from 
patches for 0.1 uM, 1 uM and 10 uM ACh (top, middle and bottom respectively) group 
fitted with gating model scheme 7 shown in Figure 3.6.
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Table A.3.1 LS based mechanism rate constants.
Table A.3.1
R a t e U n i t 0 . 1  u M 1 u M + d F B r
2k+1 M-1s1 -1 1.3E8 ± 10% 2.32E7 ± 26% 3.8E7 ± 100%
k+1 M-1s1 -1 6.7E7 ± 10% 1.16E7 ± 26% 1.9E7 ± 100%
2k-1 1571 ± 8% 2455 ± 12% 1563± 8%
k-1 785 ± 8% 1227 ± 12% 781 ± 8%
P1 106 ± 9% 114 ± 32% 139 ± 99%
a 1 539 ± 5% 671 ± 30% 185 ± 99%
P2 4100 ± 14% 1543 ±59% 221 ± 100%
a2 101 ± 13% 29 ± 98% 1 6 ± 100%
k+2 M-1s 7.1E8 ± 12% 1.1E6 ± 100% 7.6E-7 ± 100%
k-2 82 ± 9% 0.76 ± 100% 3.5E-6 ± 100%
d+1 2863 ± 18% 51 ± 11% 993 ± 33%
d-1 0.3 ± 10% 0.2 ± 11% 2.5 ± 23%
d+2 2E-7 ± 100% 0.5 ± 5% 196 ± 4%
d-2 6E-9 ± 100% 2.6E-10 ± 8% 0.33 ± 4%
s
s
s
s
s
s
1
s
s
s
s
s
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Table A.3.2: Rate constants for scheme 3 and scheme 4.
T a b l e  A . 3 . 2
R a t e  c o n s t a n t s S c h e m e  3 + d F B r S c h e m e  4 + d F B r
k01 67 ± 14% 122 ± 3.5% 66 ± 12% 17 ± 7%
k10 6580 ± 13% 6.6 ± 5% 6457 ± 11% 961 ± 11%
kO2 193± 57% 47 ± 9% 345 ± 2.4% 46.2 ± 8.9%
k20 2.4 ± 27% 0.98 ± 6% 1 8 ± 16% 7.5 ± 7.7%
k23 0.4 ± 156% 0.002 ± 80% 147 ± 21% 0.002 ± 90%
k32 0.3 ± 42% 43500 ± 100% 15 ± 11% 0.002 ± 90%
kO4 185± 59% 22.2 ± 8% 32.4 ± 13% 117 ± 3.7%
k40 41 ± 52% 1308± 12% 0.1 ± 10% 6.3 ± 5.5%
k45 208 ± 30% 6.8 ± 57%
k54 6 ± 116% 0.002 ± 600%
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Table A.3.3: Rate constants for scheme 5.
C
r ~  K  f
Ku
^  k«l / —
k,, U  k, L
c c
T a b l e  A . 3 . 3
R a t e  c o n s t a n t s S c h e m e  5 + d F B r
k1O 6955 ± 12% 13.8 ± 38%
kO1 67.5 ± 13% 45 ± 65%
k2O 279 ± 21% 0.002 ± 90%
kO2 2 8 ± 10% 0.11 ± 68%
k3O 3.5 ± 13% 1316± 13%
kO3 117 ± 11% 20 ± 8%
k4O 0.06 ± 13% 5 ± 21%
kO4 17 ± 17% 81 ± 35%
k5O 1 ± 0.01% 1 ± 0.01%
kO5 217 ± 6% 40 ± 6%
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Table A.3.4: Rate constants for scheme 6 and scheme 7.
ls„ •s.
T a b l e  A . 3 . 4
R a t e  c o n s t a n t s S c h e m e  6 + d F B r S c h e m e  7 + d F B r
k1O 1001 ± 690% 143± 15% 6428 ± 13% 1429± 13%
kO1 444 ± 610% 186 ± 2% 65 ± 13% 22 ± 9%
k12 5496 ± 861% 1088± 13%
k21 114 ± 473% 54 ± 9%
k23 173 ± 492% 2.5 ± 22% 7.9 ± 39% 2.2 ± 65%
k32 18 ± 292% 3 ± 26% 0.007 ± 42% 8 ± 54%
k34 0.23 ± 148% 0.43 ± 61%
k43 0.34 ± 109% 0.89 ± 26%
k45 5.7e-12 ± 
2600%
0.008 ± 0.06%
k54 1.8e-9 ± 2056% 0.002 ± 0.01%
kO2 31 ± 10% 127 ± 3%
k2O 208 ± 20% 7.5 ± 8%
kO4 185 ± 59% 1 ± 0.001%
k4O 1.95 ± 7% 0.008 ± 50%
kO5
k5O
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Chapter 4: Conclusions and Future Directions
4.1 General Overview
We have used single molecule methods to investigate the action of a positive 
allosteric modulator, dFBr. We have provided the first step in developing a model that 
describes the gating of the human a4p2 nicotinic receptors. Full gating models that give 
a fairly accurate representation of function allows naive and modulated receptors to be 
simulated under a range of agonist profiles and concentrations. By determining the 
mechanism of modulation for HS and LS a4p2 receptors on a single-channel level, we 
have greatly enhanced the understanding of the potential therapeutic benefit dFBr has 
on a4p2 receptors at cholinergic synapses. How dFBr modulates would be determined 
by the agonist concentration profile at a synapse. The concentration differences would 
be dependent upon the spatial differences between receptors and local neurotransmitter 
release sites.
4 . 1 . 1  d F B r  D e s t a b i l i z e s  D e s e n s i t i z e d  S t a t e s  o f  a 4 3 2  R e c e p t o r s
Models were constructed for the LS subtype of the a4p2 nAChR. It was found 
that a 7 state model based off of an MWC mechanism described our data well and 
yielded unique rate constants for naive and modulated receptors. The model contained 
two open states; a monoliganded open state off of C2 (O1) and a diliganded open state 
off of C3 (O2), as well as 5 closed states: two ligand binding steps (C1 - C2 and C2 to
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C3) and two desensitized states, one distal to C3 (D1) and the other distal to O2 (D2). 
For the LS subtype (a43022) nAChRs the primary finding was that dFBr destabilized the 
two desensitized states D1 and D2 by decreasing their mean lifetimes. The lifetime of 
D1 was decreased from 77 ms to 7.6 ms, and D2 decreased from 1.7 s to 490 ms.
Macroscopic simulations provided insight into the contribution destabilization of 
desensitized states has on modulation. State occupancy probabilities were investigated 
by driving the model with various profiles of ACh concentration. Potentiation at peak 
current exhibited by dFBr was primarily due to the destabilization of D1, which slowed 
the initial fast rate of macroscopic desensitization. Whereas, potentiation of steady 
state currents arose from a lower probability of occupying D2. The simulated dose 
response curves did not have a biphasic quality to them as seen in previous reports for 
LS receptors. The biphasic quality seen in LS receptors is due to the unique a4-a4 
binding site, which allows for the binding of one additional agonist. Unlike the LS which 
contains two unique binding sites, the HS variant of the receptor only contains one type 
of agonist binding site, and therefore does not display a biphasic dose response curve 
(Harps0e et al., 2011). Our model does not contain 3 activation steps, but still has an 
EC50 (74 ^M) close to the reported values for LS receptors (75 ^M) (Nelson et al.,
2003). While an additional activation step was tested, we found that the presence of a 
3rd activation step did not give an accurate representation of the data. It may be that 
our concentration of ACh is too low to observe activation of the low sensitivity 
component of the receptor. However, this does not account for why our simulated dose 
response curves give EC50 values similar to reported values.
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We investigated previous reports that dFBr increases peak current 3-fold under 
high agonist concentrations. Our models using single-channel data predicted less than 
1.1-fold potentiation at EC75 (300 uM), compared to the 3-fold potentiation observed in 
previous studies (Weltzin and Schulte, 2010). When occupancy probabilities were 
calculated, we found that a slow rise in ACh concentration yields a lower peak Popen for 
naive receptors and a larger increase in response when dFBr was applied. Our results 
do not support a large increase in peak current when high ACh concentrations are 
applied as seen in oocyte experiments. This discrepancy is likely in part due to slow 
solution exchange, which allows for desensitization to develop resulting in a lower peak 
amplitude in oocyte experiments.
The effects that dFBr would have on a43022 receptors would largely be 
dependent on the agonist concentration profile at the synapse. Under simulated agonist 
concentration profiles similar to that at fast synapses, dFBr increased the open 
response amplitude. If the nicotinic receptors at fast cholinergic synapses become 
saturated with agonist, then dFBr’s ability to increase peak amplitude responses would 
be relatively ineffective at increasing postsynaptic signals. For LS receptors dFBr may 
be more suited for stimuli arising from a volume transmission scenario, where 
increasing the recovery from desensitization would have the greatest impact.
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For the HS a4p2 nAChR mechanisms were constructed and their viability as an 
accurate representation of channel gating was determined. It was found that an 8 state 
mechanism, based off of a simple MWC mechanism, best described our experimental 
single-channel HS data. The mechanism was composed of two activation steps (C1-> 
C2 and C2 ->C3), two open states: a monoliganded open state off of C2 (O1) and a 
diliganded open state off of C3 (O2). The open states contained transitions between 
one another. The HS model that best described our data and contained the best overall 
fits, error values and simulated currents contained 3 desensitized states. One distal to 
C3, with an additional two desensitized states off of O2.
For the HS nAChr subtype the primary finding was that dFBr synchronizes 
receptor openings at high concentrations by increasing the opening rate. dFBr 
potentiates peak currents across all concentrations, but charge transfer is reduced at 
simulated macroscopic responses with a concentration greater than or equal to 5 ^M. 
The decrease in charge transfer at concentrations greater than 5 ^M is at due to an 
increase in desensitization. For concentrations lower than 3 ^M, the presence of dFBr 
resulted in an increase in charge transfer, reflective of a decrease in the likelihood of 
entering the desensitized state D2. The potentiation observed at low concentrations is 
brought on by the increase in the mean open lifetime of O1. While at higher 
concentrations, the increase into O2 has a larger effect on potentiation and the 
receptors desensitize more quickly.
4.1.2 Synchronization of a42023 Receptors
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With regards to signaling, the effects dFBr would have is dependent upon the 
synapse and the concentration of ACh in the synaptic cleft. dFBr has the ability to 
potentiate peak amplitude responses of HS receptors at low and high concentrations, 
but an increase in charge transfer is only observed at low concentrations. When in the 
presence of dFBr an overall decrease in charge transfer occurs, and postsynaptic 
signals generated from low frequency inputs may not benefit even though an increase in 
peak amplitude is observed over a wide range of agonist concentrations. However, 
dFBr would be the most beneficial if the receptors are exposed to low concentrations of 
agonist.
4 . 1 . 3  I m p l i c a t i o n s  f o r  N i c o t i n e  A d d i c t i o n
The pleasurable effects of nicotine occur due to the desensitization of high 
affinity nAChRs in the VTA. One of the most prominent types, a4p2 receptors, is mostly 
expressed on GABAergic neurons and dopaminergic inputs. These receptors 
desensitize rapidly when they are exposed to nicotine with the reinforcing nature of 
nicotine due to upregulation of a4 containing nAChRs on VTA GABAergic neurons 
(Nashmi et al., 2007). Receptor upregulation of a4p2 is directly related to 
desensitization, and receptors become hypersensitive after chronic exposure to nicotine 
leading to increased inhibition of dopaminergic activity (Hilario et al., 2012; Ngolab et 
al., 2015).
Our findings demonstrate that dFBr has the potential to be useful for the 
treatment of nicotine addiction. It is well known that the a4p2 receptors are upregulated
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when chronically exposed to nicotine and there is some evidence that the high 
sensitivity form may be most affected. The effect that dFBr would have on HS receptors 
is unclear in our data as we observe increased desensitization due to the presence of 
channel block or HEPES, but we find that dFBr would increase receptors 
responsiveness when exposed to ambient concentrations of ACh. In the VTA a4p2 
receptors are largely expressed on presynaptic inputs into dopaminergic neurons, and 
limiting the receptors ability to desensitize would be beneficial in reducing upregulation 
of the receptors. For LS receptors, the application of dFBr could lift receptors out of 
desensitization by destabilizing of desensitized states. This would give increased 
activity from inputs into dopaminergic neurons and could potentially lead to 
downregulation of a4p2 receptors back to normal levels, since receptor desensitization 
and upregulation have been shown to be linked (Fenster et al., 1999). The increase in 
activity within the VTA without the presence of nicotine would aid in eliminating 
symptoms of withdrawal that accompanies smoking cessation, which is one of the 
factors that prevents success in quitting (West et al., 1989).
4 . 1 . 4  I m p l i c a t i o n s  f o r  t h e  T r e a t m e n t  o f  A l z h e i m e r ’s  D i s e a s e
One possible therapeutic approach for the treatment of Alzheimer’s disease is 
through the use of compounds that interfere with nAChR-Ap interactions. Previous 
studies have looked at the interactions of dFBr and Ap on a4p2 receptors and found 
that dFBr dissociates Ap from the receptors. In our studies we found that dFBr 
increases responses for both a4p2 subtypes, making it a potential candidate for
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Alzheimer’s disease if used in conjunction with other drugs. dFBr may be best paired 
with compounds that demonstrate the ability to dissociate Ap from a7 nAChRs, 
antibodies that target Ap, or both of these options. Compounds such as 2-[2- (4- 
bromophenyl)-2-oxoethyl]-1-methyl pyridinium (S 24795), a partial a7 nAChR agonist, 
have been found to dissociate Ap in a concentration dependent manner (Wang et al., 
2009, 2010). Combining dFBr with compounds like S-24795 will combat the negative 
effects Ap binding has on a4p2 and a7 nAChRs, thereby potentially preventing further 
progression of the disease. The use of immunotherapy is still in its infancy (Goure et 
al., 2014), but the presence of compounds such as S-24795 and dFBr coupled with 
immunotherapy could potentially drastically reduce the concentration of Ap in the brain. 
dFBr’s ability to increase responses by destabilizing desensitized states for LS 
receptors and increasing open time for HS receptors could help enhance cognitive 
ability, while simultaneously dissociating Ap from receptors. Combating Alzheimer’s 
disease would require a therapy that combats the disease from many angles potentially 
utilizing multiple compounds such as dFBr.
4.2 Future Work
The investigation of dFBr on a single molecule level focused on characterizing 
the mechanisms of modulation for the a4p2 LS and HS nicotinic receptors. The goal 
was to provide a comprehensive gating model for both stoichiometric forms of the a4p2 
receptors and determine the mechanism of action for the PAM dFBr. Determining how 
allosteric modulators would behave under different forms of synaptic transmission is
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crucial to understanding the effect potentiation has on cholinergic synapses. Further 
investigation is needed into the effect structural changes have on receptors and 
allosteric modulators, and how these changes would change the mechanism of 
modulation. Understanding the structure-function relationship between dFBr analogs 
and nAChRs will help determine whether these changes increase dFBr’s viability as a 
therapeutic agent, aiding in rational drug design.
4 . 2 . 1  E f f e c t  o f  L i n k e d  S u b u n i t s  o n  a 4 p 2  G a t i n g  M o d e l s
One of the primary difficulties of doing whole cell and single-channel studies on 
receptors that contain more than one subtype, is receptor heterogeneity. While single­
channel helps circumvent heterogeneity, more than one subtype can still be present in a 
patch adding complexity to data analysis. Many attempts have been made to address 
this problem and express a43p22 (LS) and a42p23 (HS) receptors separately. Strategies 
include using a 1:4 or 4:1 (or larger) ratio of a4:p2 subunit cDNAs for injecting or 
transfecting into the appropriate cell line. This technique gives monophasic 
concentration profiles, which suggests that there are homologous population of either 
a43p22 or a42p23 subtype (Moroni et al., 2006; Nelson et al., 2003), but it is currently 
unknown if this technique abolishes the unwanted stoichiometric form of the receptor. 
Alternatively, constructs with two units attached via synthetic linkers can be used to 
constrain the stoichiometry of a4p2 receptors (Zhou et al., 2003). These studies would 
be done on two linker configurations a4-6-p2 and p2-6-a4 in order to determine if the 
position of the linker has any noticeable effect on the desensitization or bursting 
characteristics of the receptor. With these studies the linker would have to be added to
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the transfection medium in a 2:1 ratio of a4-6-p2/ p2-6-a4 to a4/p2 cDNAs, depending 
on the subtype being studied. Linkers also have the advantage of being able to be 
combined with mutated subunits, allowing for greater insight into the effects of 
mutations on gating. Conducting single molecule studies on receptors that contain 
mutations would increase understanding of the structure function relationship for the 
receptors, and determine if mutations affect activation, burst, and desensitization 
kinetics. Preliminary work for this project involved introducing the linked subunit cDNA 
into a mammalian vector. Investigation into whether the naive receptors kinetics differ 
from that of linked receptors would also be beneficial for future studies utilizing linked 
subunits.
4 . 2 . 2  I n v e s t i g a t i o n  o f  d F B r  A n a l o g u e s
The compound being studied, dFBr, has potential drawbacks in its use as an 
effective therapeutic agent. Being a natural product, dFBr could have poor transit 
across the blood brain barrier, selectivity, and efficacy. A nicotine self-administration 
study conducted with rats administered with dFBr demonstrated that dFBr is present in 
cerebral fluid. This finding indicates that dFBr crosses the blood-brain barrier, but is 
available only at one-third the concentration compared to blood. There is room for 
improvement with dFBr’s qualities, including the compounds ability to transit across the 
blood brain barrier (Liu, 2013). In order for dFBr to be considered an effective 
therapeutic treatment dFBr needs to be improved and made more selective in its 
therapeutic target. To accomplish this, analogues can be tested to determine what
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structural aspects of dFBr are important for modulation. Single-channel analysis would 
help in determining if a change in structure affected dFBr’s mechanism of modulation 
and therefore which components are most important. These studies would be done 
using five dFBr analogues with EC50s ranging from 1 to 6.3 ^M and IC50s from 8 to 90 
pM, with some analogues only displaying inhibition. An optimal ligand for both receptor 
subtypes would destabilize desensitized states as well as increase peak current across 
a wide range of concentrations. Determining the structural components that exhibit 
potentiation via destabilization of desensitized states versus potentiation of peak current 
would allow for a therapeutic agent that has more specificity. Currently, at high 
concentrations of agonist dFBr only destabilizes desensitized states on the LS subtype, 
while increasing desensitization on the HS subtype. Peak current at high 
concentrations of agonist for the HS subtype is still modulated by dFBr, whereas the LS 
subtype is not. Analogues would help elucidate if dFBr can become more selective in 
its actions for the HS versus LS subtype, enhancing its potential as a therapeutic agent. 
Studies investigating the effects structural modifications have on a single-channel level 
furthers the drug design process and leads to more rational drug design.
4 . 2 . 3  I n v e s t i g a t i o n  o f  t h e  M e c h a n i s m s  o f  A c t i o n  o f  N S 2 0 6  a n d  N S 9 2 8 3
The positive allosteric modulator dFBr displays two types of modulation, affecting 
desensitization as well as peak currents. Unlike dFBr, NS206 and NS9283 compounds 
each display a single type of modulation via different mechanisms. The compounds 
differ in their structure as well as their binding sites, and thus behave very differently.
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NS206 potentiates both stoichiometric forms of the receptor displaying higher efficacy 
on HS receptors increasing ACh evoked currents 3-4fold and potentiates LS receptors 
1.5 fold. While NS206 potentiates both stoichiometric forms of the receptor, NS9283 
potentiates only the LS form of the a4p2 receptor (Grupe et al., 2013). Further 
comparison on the differences between the two compounds, it is found that NS9283 
increases potency and gives monophasic properties. Whereas NS206 displays no 
change in ACh potency and for the LS subtype continues to have biphasic properties 
(Olsen et al., 2013). Both compounds do not affect receptor desensitization for either 
stoichiometry and when co-applied, work additively. It would be worthwhile 
investigating how the mechanisms of modulation differ between these two compounds, 
whether there is an additive effect on the single-channel level, and if the mechanisms 
are similar in form to dFBr’s mechanism. Conducting single-channel analysis on two 
compounds that give rise to individual types of modulation, differ in structure, and 
mechanism would help increase understanding on what aspects of the a4p2 nAChR 
kinetic mechanism the compounds affect the most and if all PAMs display similar modes 
of action. Developing an understanding of the relationship between compound 
structure, kinetic mechanisms and binding sites is an important aspect of intelligent and 
efficient drug development.
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